Nucleic acid testing and molecular characterization of HIV infections
Significant advances have been made in the molecular assays used for the detection of human immunodeficiency virus (HIV), which are crucial in preventing HIV transmission and monitoring disease progression. Molecular assays for HIV diagnosis have now reached a high degree of specificity, sensitivity...
Saved in:
| Published in | European Journal of Clinical Microbiology & Infectious Diseases Vol. 38; no. 5; pp. 829 - 842 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
Berlin/Heidelberg
Springer Science and Business Media LLC
01.05.2019
Springer Berlin Heidelberg Springer Nature B.V |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Significant advances have been made in the molecular assays used for the detection of human immunodeficiency virus (HIV), which are crucial in preventing HIV transmission and monitoring disease progression. Molecular assays for HIV diagnosis have now reached a high degree of specificity, sensitivity and reproducibility, and have less operator involvement to minimize risk of contamination. Furthermore, analyses have been developed for the characterization of host gene polymorphisms and host responses to better identify and monitor HIV-1 infections in the clinic. Currently, molecular technologies including HIV quantitative and qualitative assays are mainly based on the polymerase chain reaction (PCR), transcription-mediated amplification (TMA), nucleic acid sequence-based amplification (NASBA), and branched chain (b) DNA methods and widely used for HIV detection and characterization, such as blood screening, point-of-care testing (POCT), pediatric diagnosis, acute HIV infection (AHI), HIV drug resistance testing, antiretroviral (AR) susceptibility testing, host genome polymorphism testing, and host response analysis. This review summarizes the development and the potential utility of molecular assays used to detect and characterize HIV infections. |
|---|---|
| AbstractList | Significant advances have been made in the molecular assays used for the detection of human immunodeficiency virus (HIV), which are crucial in preventing HIV transmission and monitoring disease progression. Molecular assays for HIV diagnosis have now reached a high degree of specificity, sensitivity and reproducibility, and have less operator involvement to minimize risk of contamination. Furthermore, analyses have been developed for the characterization of host gene polymorphisms and host responses to better identify and monitor HIV-1 infections in the clinic. Currently, molecular technologies including HIV quantitative and qualitative assays are mainly based on the polymerase chain reaction (PCR), transcription-mediated amplification (TMA), nucleic acid sequence-based amplification (NASBA), and branched chain (b) DNA methods and widely used for HIV detection and characterization, such as blood screening, point-of-care testing (POCT), pediatric diagnosis, acute HIV infection (AHI), HIV drug resistance testing, antiretroviral (AR) susceptibility testing, host genome polymorphism testing, and host response analysis. This review summarizes the development and the potential utility of molecular assays used to detect and characterize HIV infections. Significant advances have been made in the molecular assays used for the detection of human immunodeficiency virus (HIV), which are crucial in preventing HIV transmission and monitoring disease progression. Molecular assays for HIV diagnosis have now reached a high degree of specificity, sensitivity and reproducibility, and have less operator involvement to minimize risk of contamination. Furthermore, analyses have been developed for the characterization of host gene polymorphisms and host responses to better identify and monitor HIV-1 infections in the clinic. Currently, molecular technologies including HIV quantitative and qualitative assays are mainly based on the polymerase chain reaction (PCR), transcription-mediated amplification (TMA), nucleic acid sequence-based amplification (NASBA), and branched chain (b) DNA methods and widely used for HIV detection and characterization, such as blood screening, point-of-care testing (POCT), pediatric diagnosis, acute HIV infection (AHI), HIV drug resistance testing, antiretroviral (AR) susceptibility testing, host genome polymorphism testing, and host response analysis. This review summarizes the development and the potential utility of molecular assays used to detect and characterize HIV infections.Significant advances have been made in the molecular assays used for the detection of human immunodeficiency virus (HIV), which are crucial in preventing HIV transmission and monitoring disease progression. Molecular assays for HIV diagnosis have now reached a high degree of specificity, sensitivity and reproducibility, and have less operator involvement to minimize risk of contamination. Furthermore, analyses have been developed for the characterization of host gene polymorphisms and host responses to better identify and monitor HIV-1 infections in the clinic. Currently, molecular technologies including HIV quantitative and qualitative assays are mainly based on the polymerase chain reaction (PCR), transcription-mediated amplification (TMA), nucleic acid sequence-based amplification (NASBA), and branched chain (b) DNA methods and widely used for HIV detection and characterization, such as blood screening, point-of-care testing (POCT), pediatric diagnosis, acute HIV infection (AHI), HIV drug resistance testing, antiretroviral (AR) susceptibility testing, host genome polymorphism testing, and host response analysis. This review summarizes the development and the potential utility of molecular assays used to detect and characterize HIV infections. |
| Author | Le Chang Junpeng Zhao Lunan Wang |
| Author_xml | – sequence: 1 givenname: Junpeng surname: Zhao fullname: Zhao, Junpeng organization: National Center for Clinical Laboratories, Beijing Hospital, National Center of Gerontology, Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital, Graduate School, Peking Union Medical College, Chinese Academy of Medical Sciences – sequence: 2 givenname: Le surname: Chang fullname: Chang, Le organization: National Center for Clinical Laboratories, Beijing Hospital, National Center of Gerontology, Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital – sequence: 3 givenname: Lunan orcidid: 0000-0002-8208-1718 surname: Wang fullname: Wang, Lunan email: lunan99@163.com organization: National Center for Clinical Laboratories, Beijing Hospital, National Center of Gerontology, Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital, Graduate School, Peking Union Medical College, Chinese Academy of Medical Sciences |
| BackLink | https://cir.nii.ac.jp/crid/1871709542497864320$$DView record in CiNii https://www.ncbi.nlm.nih.gov/pubmed/30798399$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kc1O3DAUha0KVKZTXqCLKlJZsAn4L7bvshoBg4RgQ7u1HMcGo4xD7WRBn77OhLYSCzb3StZ3fI7u-YQO4hAdQl8IPiMYy_NcJogaE6gxa0hT4w9oRThras4kO0ArDIzXICk7Qsc5hxbTwgHH8BEdMSxBMYAVuridbO-CrYwNXTW6PIb4UJnYVbuhd3bqTarso0nGji6F32YMQ6wGX22vf1Yhemfnh_wZHXrTZ3f8utfox-XF_WZb39xdXW--39SWSzzWxHrFjXTC89Y31pXYEjpBoW1lJ7gyyjpKVEsBN63ktPWCOt8ZYZgXpMNsjU6Xf5_T8GsqYfUuZOv63kQ3TFkXcaOkhGZGv71Bn4YpxZJuTxGQgEWhvr5SU7tznX5OYWfSi_57oALQBbBpyDk5_w8hWM9F6KUIXYrQ-yL07K3eiGwY96cbkwn9-1K2SHPxiQ8u_Y_9rupkUcUQitc8iZJEYmg45SCV4KzU_wfhKKUj |
| CitedBy_id | crossref_primary_10_1016_j_cclet_2021_06_025 crossref_primary_10_1111_hiv_13363 crossref_primary_10_1016_j_acpath_2022_100046 crossref_primary_10_1039_D1AN00598G crossref_primary_10_2174_1570162X19666210910144433 crossref_primary_10_3390_s22041620 crossref_primary_10_1039_D0RA03833D crossref_primary_10_1039_D0AN01014F crossref_primary_10_3390_life15020209 crossref_primary_10_1038_s41378_024_00822_1 crossref_primary_10_1021_acssensors_0c00497 crossref_primary_10_3390_v13122492 crossref_primary_10_3390_ijms23094620 crossref_primary_10_1002_emp2_12468 crossref_primary_10_1007_s11901_021_00567_9 crossref_primary_10_1016_j_talanta_2019_120201 crossref_primary_10_1007_s10544_020_00494_4 crossref_primary_10_1128_jcm_02446_21 crossref_primary_10_1186_s12879_023_08492_6 |
| Cites_doi | 10.1089/088922204322749495 10.1128/JCM.00362-16 10.1016/j.ebiom.2017.05.006 10.1590/S0100-879X2007000300003 10.1371/journal.pone.0184929 10.1016/j.kjms.2014.12.010 10.7326/0003-4819-135-9-200111060-00008 10.1016/j.cell.2013.09.020 10.1146/annurev-genom-082908-150116 10.1371/journal.pone.0147421 10.1016/j.jviromet.2013.01.017 10.1016/j.jcv.2006.12.022 10.1017/S0950268818001218 10.1021/bi952950g 10.1097/QAD.0000000000000243 10.1016/j.jcv.2010.10.001 10.1371/journal.pone.0055943 10.1586/14737159.6.3.399 10.1111/trf.12298 10.1016/j.jviromet.2006.03.018 10.1111/trf.13193 10.2174/1874613600802010017 10.3390/v7082816 10.1046/j.1537-2995.1999.39101141.x 10.1097/OLQ.0000000000000736 10.1097/QAI.0000000000001770 10.1016/j.celrep.2016.03.042 10.1128/JVI.01046-14 10.1128/JCM.02183-10 10.1080/14656566.2017.1363180 10.1126/science.272.5265.1167 10.1097/00042560-199703010-00009 10.1007/978-1-62703-290-2_12 10.1056/NEJMra1505256 10.1016/j.jcv.2017.10.013 10.1128/JCM.00317-09 10.1111/j.1537-2995.2009.02203.x 10.1097/QAD.0000000000000206 10.3390/v8020048 10.1111/j.1537-2995.2008.01965.x 10.1093/nar/25.23.4842 10.1001/jama.2010.925 10.1038/srep13811 10.1016/S0140-6736(98)06318-1 10.1093/cid/ciy565 10.1371/journal.pcbi.1002899 10.1097/QAI.0000000000001394 10.1111/trf.12190 10.1182/blood-2011-10-381996 10.1097/QAD.0000000000001882 10.1111/j.1537-2995.2011.03281.x 10.2147/IDR.S165811 10.1056/NEJMoa0802905 10.1038/pr.2016.183 10.1111/j.1537-2995.2008.01966.x 10.1515/cclm-2017-0910 10.1586/14737159.2015.960518 10.1159/000332013 10.7448/IAS.20.1.21171 10.1016/j.ijid.2008.03.032 10.1128/JCM.02204-08 10.1097/00002030-199813000-00011 10.1084/jem.20121827 10.1016/j.jviromet.2011.08.020 10.1016/j.coviro.2015.06.001 10.1586/14737159.2.3.275 10.1371/journal.pone.0118149 10.1128/CMR.00090-15 10.1097/00002030-199812000-00018 10.1016/j.jviromet.2015.12.007 10.1128/JCM.41.4.1586-1593.2003 10.1016/S0166-0934(97)00178-X 10.1093/infdis/158.6.1158 10.1128/JCM.02833-15 10.1086/512088 10.1586/14737159.2013.829703 10.1128/JCM.03325-14 10.1371/journal.pone.0033295 10.1371/journal.pone.0152513 10.1021/jm100073m 10.1073/pnas.96.16.9236 10.1097/QAD.0000000000000556 10.1016/j.jviromet.2012.08.019 10.1111/voxs.12106 10.1159/000446217 10.1186/s12977-015-0150-z 10.1016/j.tim.2013.06.004 10.1093/jac/dkv046 10.16966/2380-5536.135 10.1128/JCM.42.6.2711-2717.2004 10.1016/j.jcv.2013.08.005 10.1126/science.3336784 10.1128/JCM.02008-10 10.1128/JCM.02231-08 10.1093/infdis/jix470 10.1128/JCM.01350-16 10.2174/1874613601509010009 10.1093/infdis/jir793 10.1128/JVI.01589-17 10.1128/JCM.01525-13 10.1016/j.jviromet.2004.08.018 10.1093/infdis/jix413 10.1128/JCM.01832-09 10.1186/s13578-017-0174-2 10.3389/fpubh.2017.00032 10.1007/978-1-4614-2251-8_4 10.1111/trf.14457 10.1016/j.jcv.2015.08.007 10.1128/JVI.01414-12 10.1046/j.1537-2995.2002.00101.x 10.1371/journal.ppat.1005545 10.1007/BF03256386 10.1097/QAI.0000000000001198 10.1016/j.jcv.2017.09.010 10.1128/JCM.00292-18 10.1016/j.jcv.2013.07.016 10.1016/S0140-6736(13)61221-0 10.1001/jama.283.9.1175 10.1111/j.1468-1293.2010.00850.x 10.1016/j.jviromet.2012.11.044 10.1371/journal.pone.0152672 10.1111/j.1537-2995.2007.01343.x 10.1016/j.jcv.2014.06.013 10.1186/s12977-018-0399-0 10.1016/j.exphem.2015.02.006 10.1097/COH.0b013e32833a6b11 |
| ContentType | Journal Article |
| Copyright | Springer-Verlag GmbH Germany, part of Springer Nature 2019 European Journal of Clinical Microbiology & Infectious Diseases is a copyright of Springer, (2019). All Rights Reserved. |
| Copyright_xml | – notice: Springer-Verlag GmbH Germany, part of Springer Nature 2019 – notice: European Journal of Clinical Microbiology & Infectious Diseases is a copyright of Springer, (2019). All Rights Reserved. |
| DBID | RYH AAYXX CITATION NPM 3V. 7QL 7U9 7X7 7XB 88A 88E 8AO 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7N M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI 7X8 |
| DOI | 10.1007/s10096-019-03515-0 |
| DatabaseName | CiNii Complete CrossRef PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic |
| DatabaseTitle | CrossRef PubMed ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection Environmental Sciences and Pollution Management ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | ProQuest Central Student PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Biology |
| EISSN | 1435-4373 |
| EndPage | 842 |
| ExternalDocumentID | 30798399 10_1007_s10096_019_03515_0 |
| Genre | Journal Article Review |
| GroupedDBID | --- -~C .86 .VR 06C 06D 0R~ 0VY 199 1N0 203 29G 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2~H 30V 36B 4.4 406 408 409 40D 40E 5RE 5VS 67N 67Z 6NX 78A 7X7 88E 8AO 8CJ 8FE 8FH 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANZL AAPKM AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYZH ABAKF ABBBX ABBRH ABBXA ABDBE ABDZT ABECU ABFSG ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABLJU ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTHY ABTKH ABTMW ABUWG ABWNU ABXPI ACAOD ACDTI ACGFS ACHSB ACHVE ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACSTC ACZOJ ADBBV ADHHG ADHIR ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEFQL AEGAL AEGNC AEJHL AEJRE AEMSY AENEX AEOHA AEPYU AESKC AETLH AEUYN AEVLU AEXYK AEZWR AFBBN AFDZB AFHIU AFKRA AFLOW AFOHR AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHPBZ AHSBF AHWEU AHYZX AIAKS AIGIU AIIXL AILAN AITGF AIXLP AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ATHPR AXYYD AYFIA AZFZN B-. BA0 BBNVY BDATZ BENPR BGNMA BHPHI BPHCQ BSONS BVXVI CCPQU CSCUP D1J DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMB EMOBN EPAXT ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ7 GQ8 GXS HCIFZ HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KPH LAS LK8 LLZTM M1P M4Y M7P MA- MM. N9A NB0 NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 PF0 PHGZM PHGZT PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R89 R9I RHV ROL RPX RRX RSV RYH S16 S27 S3A S3B SAP SBL SDH SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 TSG TSK TSV TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 YLTOR Z45 ZMTXR ZOVNA ~EX ~KM -4W -56 -5G -BR -EM 88A AAAVM ADINQ GQ6 M0L Z7U Z7W Z7X Z81 Z82 Z83 Z87 Z8O Z8Q Z8V Z91 -Y2 .55 .GJ 1SB 2.D 28- 2P1 2VQ 3O- 3SX 53G 5QI AANXM AARHV AAYTO AAYXX ABQSL ABULA ACBXY ADHKG ADYPR AEBTG AEFIE AEKMD AFEXP AFGCZ AGGDS AGJBK AGQPQ AI. AJBLW BBWZM CAG CITATION COF EN4 H13 KOW N2Q NDZJH OVD RNI RZK S1Z S26 S28 SBY SCLPG T16 TEORI VH1 WK6 X7M ZGI ZXP ABRTQ NPM PJZUB PPXIY PQGLB 3V. 7QL 7U9 7XB 8FK AZQEC C1K DWQXO GNUQQ H94 K9. M7N PKEHL PQEST PQUKI 7X8 |
| ID | FETCH-LOGICAL-c470t-1cf84a7e6f4bf5ce51579d629bb7d648a8ce218b2905b742bf62efda6a3f61d03 |
| IEDL.DBID | 7X7 |
| ISSN | 0934-9723 1435-4373 |
| IngestDate | Fri Jul 11 03:10:38 EDT 2025 Fri Jul 25 19:17:06 EDT 2025 Mon Jul 21 06:05:49 EDT 2025 Thu Apr 24 23:07:28 EDT 2025 Tue Jul 01 04:08:26 EDT 2025 Fri Feb 21 02:39:02 EST 2025 Thu Jun 26 23:30:17 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Keywords | Characterization Qualitative nucleic acid assays Human immunodeficiency virus Nucleic acid testing Quantitative nucleic assays |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c470t-1cf84a7e6f4bf5ce51579d629bb7d648a8ce218b2905b742bf62efda6a3f61d03 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Literature Review-3 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0002-6154-7304 0000-0002-8208-1718 0000-0003-3163-7891 |
| PMID | 30798399 |
| PQID | 2185197906 |
| PQPubID | 54107 |
| PageCount | 14 |
| ParticipantIDs | proquest_miscellaneous_2185877950 proquest_journals_2185197906 pubmed_primary_30798399 crossref_primary_10_1007_s10096_019_03515_0 crossref_citationtrail_10_1007_s10096_019_03515_0 springer_journals_10_1007_s10096_019_03515_0 nii_cinii_1871709542497864320 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2019-05-01 |
| PublicationDateYYYYMMDD | 2019-05-01 |
| PublicationDate_xml | – month: 05 year: 2019 text: 2019-05-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Berlin/Heidelberg |
| PublicationPlace_xml | – name: Berlin/Heidelberg – name: Germany – name: Heidelberg |
| PublicationTitle | European Journal of Clinical Microbiology & Infectious Diseases |
| PublicationTitleAbbrev | Eur J Clin Microbiol Infect Dis |
| PublicationTitleAlternate | Eur J Clin Microbiol Infect Dis |
| PublicationYear | 2019 |
| Publisher | Springer Science and Business Media LLC Springer Berlin Heidelberg Springer Nature B.V |
| Publisher_xml | – name: Springer Science and Business Media LLC – name: Springer Berlin Heidelberg – name: Springer Nature B.V |
| References | JaniIVMeggiBVubilASitoeNEBhattNTobaiwaOEvaluation of the whole-blood Alere Q NAT point-of-care RNA assay for HIV-1 viral load monitoring in a primary health care setting in MozambiqueJ Clin Microbiol20165482104210810.1128/JCM.00362-161:CAS:528:DC%2BC2sXhsFyjsr%2FI272524594963486 AbbottMAPoieszBJByrneBCKwokSSninskyJJEhrlichGDEnzymatic gene amplification: qualitative and quantitative methods for detecting proviral DNA amplified in vitroJ Infect Dis198815861158116910.1093/infdis/158.6.11581:CAS:528:DyaL1MXhvVylsL0%3D3198934 SusanAFTakeshaMJulieAENWilliamCMValidation of the gen-probe Aptima qualitative HIV-1 RNA assay for diagnosis of human immunodeficiency virus infection in infantsJ Clin Microbiol201351124137414010.1128/JCM.01525-131:CAS:528:DC%2BC2cXhsVGks7rL MartinEGSalaruGMohammedDCoombsRWPaulSMCadoffEMFinding those at risk: acute HIV infection in Newark, NJJ Clin Virol201358E24E2810.1016/j.jcv.2013.07.016239539414266376 SkerljRTBridgerGJKallerAMceachernEJCrawfordJBZhouYDiscovery of novel small molecule orally bioavailable C-X-C chemokine receptor 4 antagonists that are potent inhibitors of T-tropic (X4) HIV-1 replicationJ Med Chem20105383376338810.1021/jm100073m1:CAS:528:DC%2BC3cXjs1Wrs7c%3D20297846 DumoulinAHirschHHReevaluating and optimizing polyomavirus BK and JC real-time PCR assays to detect rare sequence polymorphismsJ Clin Microbiol2011494138210.1128/JCM.02008-101:CAS:528:DC%2BC3MXhtFKrt7nM213255603122792 ZhuWLeiRDuffYLLiJGuoFWainbergMAThe CRISPR/Cas9 system inactivates latent HIV-1 proviral DNARetrovirology20151212210.1186/s12977-015-0150-z1:CAS:528:DC%2BC2MXmsFGgsLc%3D258084494359768 YuchaRWHobbsKSHanhauserEHoganLENievesWOzenMOHigh-throughput characterization of HIV-1 reservoir reactivation using a single-cell-in-droplet PCR assayEbiomedicine201720C21722910.1016/j.ebiom.2017.05.006285290335478213 (2018) HIV/AIDS Fact sheets, http://www.who.int/en/news-room/fact-sheets/detail/hiv-aids UltraQual HIV-1 RT-PCR Assay, https://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/ucm172937.htm DoddRYTransfusion-transmitted infections: testing strategies and residual riskIsbt Science20159115 D'AntoniMLPaulRHMitchellBIKohornLFischerLLefebvreEImproved cognitive performance and reduced monocyte activation in virally suppressed chronic HIV following dual CCR2 and CCR5 antagonismJ Acquir Immune Defic Syndr2018791110.1097/QAI.00000000000017701:CAS:528:DC%2BC1cXhsFSqs7zI (2010) WHO Guidelines Approved by the Guidelines Review Committee. WHO Recommendations on the Diagnosis of HIV Infection in Infants and Children. World Health Organization World Health Organization., Geneva ShyamalaVNucleic acid technology (NAT) testing for blood screening: impact of individual donation and Mini Pool-NAT testing on analytical sensitivity, screening sensitivity and clinical sensitivityIsbt Science20159231532410.1111/voxs.121061:CAS:528:DC%2BC2cXitVCisb7P DuarteHAPanpradistNBeckIALutzBLaiJKanthulaRMCurrent status of point-of-care testing for human immunodeficiency virus drug resistanceJ Infect Dis2017216suppl_9S824s82810.1093/infdis/jix4131:CAS:528:DC%2BC1cXisVCns7jF290406215853236 RobertMGDanielRKVictoriaAJJohnWMJohnLSRonaldSAccuracy of the TRUGENE HIV-1 genotyping kitJ Clin Microbiol2003414158610.1128/JCM.41.4.1586-1593.20031:CAS:528:DC%2BD3sXjsVOnu7k%3D LiuZChenSJinXWangQYangKLiCGenome editing of the HIV co-receptors CCR5 and CXCR4 by CRISPR-Cas9 protects CD4 + T cells from HIV-1 infectionCell Biosci2017714710.1186/s13578-017-0174-21:CAS:528:DC%2BC1cXltlKltbk%3D289047455591563 MayMTGompelsMDelpechVPorterKOrkinCKeggSImpact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapyAids20142881193120210.1097/QAD.0000000000000243245568694004637 JuliaDNienkeVTendaiMBregjeDBAOttoSAHazenbergMDReconciling longitudinal naive T-cell and TREC dynamics during HIV-1 infectionPLoS One2016113e015251310.1371/journal.pone.01525131:CAS:528:DC%2BC28Xht1amt7jE MiguelesSAConnorsMLong-term nonprogressive disease among untreated HIV-infected individuals: clinical implications of understanding immune control of HIVJama2010304219420110.1001/jama.2010.9251:CAS:528:DC%2BC3cXovFGgsL0%3D20628133 GooLJalalianlechakZRichardsonBAOverbaughJA combination of broadly neutralizing HIV-1 monoclonal antibodies targeting distinct epitopes effectively neutralizes variants found in early infectionJ Virol20128619108571086110.1128/JVI.01414-121:CAS:528:DC%2BC38XhtlOmtbjI228372043457273 Van LaethemKBeuselinckKVan DoorenSDe ClercqEDesmyterJVandammeAMDiagnosis of human immunodeficiency virus infection by a polymerase chain reaction assay evaluated in patients harbouring strains of diverse geographical originJ Virol Methods199870215316610.1016/S0166-0934(97)00178-X9562409 RagoussisJGenotyping technologies for genetic researchAnnu Rev Genomics Hum Genet200910111713310.1146/annurev-genom-082908-1501161:CAS:528:DC%2BD1MXht12qsrvN19453250 BransonBMSteklerJDDetection of acute HIV infection: we can’t close the windowJ Infect Dis2012205452152410.1093/infdis/jir79322207652 EmersonBPloughKDetection of acute HIV-1 infections utilizing NAAT technology in Dallas, TexasJ Clin Virol201358Suppl 1e48e5310.1016/j.jcv.2013.08.00523999031 TsukamotoTTranscriptional gene silencing limits CXCR4-associated depletion of bone marrow CD34+ cells in HIV-1 infectionAids201832131737174710.1097/QAD.00000000000018821:CAS:528:DC%2BC1cXhtlOktLfL29762163 HütterGBodorJLedgerSBoydMMillingtonMTsieMCCR5 targeted cell therapy for HIV and prevention of viral escapeViruses2015784186420310.3390/v70828161:CAS:528:DC%2BC2MXhslOqt77N262259914576177 Human immunodeficiency virus, type 1 (HIV-1) REVERSE TRANSCRIPTION (RT) polymerase chain reaction (PCR) assay, https://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/ucm093501.htm PasSRossenJWSchoenerDThamkeDPetterssonABabielRPerformance evaluation of the new Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 for quantification of human immunodeficiency virus type 1 RNAJ Clin Microbiol20104841195120010.1128/JCM.01832-091:CAS:528:DC%2BC3cXmt1Kgtbs%3D201642812849552 StahlTBöhmeMUKrögerNFehseBDigital PCR to assess hematopoietic chimerism after allogeneic stem cell transplantationExp Hematol2015436462468.e46110.1016/j.exphem.2015.02.0061:CAS:528:DC%2BC2MXns1Oru7s%3D2579552325795523 HamlynEJonesVPorterKFidlerSAntiretroviral treatment of primary HIV infection to reduce onward transmissionCurr Opin HIV AIDS20105428329010.1097/COH.0b013e32833a6b1120543602 HsiaoNYDunningLKroonMMyerLLaboratory evaluation of the Alere q point-of-care system for early infant HIV diagnosisPLoS One2016113e015267210.1371/journal.pone.01526721:CAS:528:DC%2BC28XhtVOlsrnO270320944816318 APTIMA HIV-1 RNA Qualitative Assay, https://www.fda.gov/downloads/BiologicsBloodVaccines-/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/UCM149927.pdf ZulfiqarHFJavedASumbalAfrozeBAliQAkbarKHIV diagnosis and treatment through advanced technologiesFront Public Health201753210.3389/fpubh.2017.00032283263045339269 GrabarczykPKoppelmanMBolandFSauledaSFabraCCambieGInclusion of human immunodeficiency virus type 2 (HIV-2) in a multiplex transcription-mediated amplification assay does not affect detection of HIV-1 and hepatitis B and C virus genotypes: a multicenter performance evaluation studyTransfusion20155592246225510.1111/trf.131931:CAS:528:DC%2BC2MXhsFGit7fI26103564 IoannidisJPARosenbergPSGoedertJJAshtonLJBenfieldTLBuchbinderSPEffects of CCR5-Δ 32, CCR2-64I, and SDF-1 3′a alleles on HIV-1 disease progression: an international meta-analysis of individual-patient dataAnn Intern Med2001135978279510.7326/0003-4819-135-9-200111060-000081:CAS:528:DC%2BD3MXotlyks7Y%3D11694103 HornTChangCAUrdeaMSChemical synthesis and characterization of branched oligodeoxyribonucleotides (bDNA) for use as signal amplifiers in nucleic acid quantification assaysNucleic Acids Res199725234842484910.1093/nar/25.23.48421:CAS:528:DyaK1cXhslGltw%3D%3D9365266147109 TungYCKeLYLuPLLinKHLeeSCLinYYComparison of the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 test V1.0 with V2.0 in HIV-1 viral load quantificationKaohsiung J Med Sci201531418819310.1016/j.kjms.2014.12.01025835274 StrainMCLadaSMLuongTRoughtSEGianellaSTerryVHHighly precise measurement of HIV DNA by droplet digital PCRPLoS One201384e5594310.1371/journal.pone.00559431:CAS:528:DC%2BC3sXmtFWrtLY%3D235731833616050 MargaritisARBrownSMSeedCRKielyPD'AgostinoBKellerAJComparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNATransfusion200747101783179310.1111/j.1537-2995.2007.01343.x1:CAS:528:DC%2BD2sXht1elsrvM17880602 GrantRMLieglerTDefechereuxPKashubaADTaylorDAbdelmohsenMDrug resistance and plasma viral RNA level after ineffective use of oral pre-exposure prophylaxis in womenAids201529333110.1097/QAD.00000000000005561:CAS:528:DC%2BC2MXisl2ntr4%3D25503265 Procleix Ultrio Assay, https://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProd-ucts/ApprovedProducts/LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/UCM335285.pdf StelzlEProllJBizonBNiklasNDanzerMHacklCHuman immunodeficiency virus type 1 drug resistance testing: evaluation of a new ultra-deep sequencing-based protocol and comparison with the TRUGENE HIV-1 genotyping kitJ Virol Methods20111781–2949710.1016/j.jviromet.2011.08.0201:CAS:528:DC%2BC3MXhtlKrtr7J21907239 Aptima HIV-1 Quant Assay, https://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/PremarketApprovalsPMAs/UCM534609.pdf CahnPPozniakALMingroneHShuldyakovABritesCAndrade-VillanuevaJFDolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING studyLancet2013382989370070810.1016/S0140-6736(13)61221-01:CA S Paraschiv (3515_CR111) 2009; 13 SA Migueles (3515_CR81) 2010; 304 S Mohamed (3515_CR109) 2014; 14 CR Sloma (3515_CR51) 2009; 47 K Devadas (3515_CR133) 2016; 11 B Müller (3515_CR18) 2013; 53 HC Tsai (3515_CR104) 2018; 11 P Gomes (3515_CR29) 2006; 135 G Hancock (3515_CR140) 2017; 20 CY Ou (3515_CR6) 1988; 239 3515_CR67 A Heim (3515_CR78) 2016; 43 ME Quinones-Mateu (3515_CR118) 2014; 61 3515_CR63 L Scott (3515_CR101) 2015; 53 B Weber (3515_CR14) 2006; 6 MT May (3515_CR45) 2014; 28 MA Baumeister (3515_CR61) 2012; 7 BM Branson (3515_CR13) 2012; 205 M Samson (3515_CR153) 1996; 35 K Korn (3515_CR53) 2009; 47 C-Y Ou (3515_CR87) 2012; 743 MLC Mekue (3515_CR110) 2015; 9 Z Wang (3515_CR158) 2016; 15 T Stahl (3515_CR144) 2015; 43 S Ceffa (3515_CR90) 2016; 229 N Engel (3515_CR98) 2015; 15 3515_CR102 MM Manak (3515_CR56) 2016; 54 3515_CR105 G Touloumi (3515_CR136) 2004; 20 A Assal (3515_CR75) 2009; 49 K Luzuriaga (3515_CR84) 2016; 374 TJ Henrich (3515_CR151) 2012; 186 HF Zulfiqar (3515_CR156) 2017; 5 NY Hsiao (3515_CR91) 2016; 11 D Mendoza (3515_CR82) 2012; 119 PN Lelie (3515_CR66) 2010; 42 T Horn (3515_CR50) 1997; 25 B Emerson (3515_CR96) 2013; 58 D Julia (3515_CR135) 2016; 11 W Zhu (3515_CR157) 2015; 12 A Pironti (3515_CR103) 2017; 74 S Rutsaert (3515_CR149) 2018; 15 M Thiam (3515_CR119) 2013; 188 LE Mccoy (3515_CR143) 2013; 210 P Grabarczyk (3515_CR77) 2015; 55 GJPV Westen (3515_CR108) 2013; 9 3515_CR117 WK Roth (3515_CR64) 1999; 353 E Stelzl (3515_CR112) 2011; 178 ML D'Antoni (3515_CR126) 2018; 79 K Laethem Van (3515_CR71) 1998; 70 L Goo (3515_CR142) 2012; 86 IFT Viana (3515_CR5) 2018; 146 M Chudy (3515_CR72) 2012; 52 J Ha (3515_CR80) 2017; 96 T Pattery (3515_CR106) 2012; 55 3515_CR19 T Mourez (3515_CR55) 2015; 71 3515_CR128 PJ McLaren (3515_CR122) 2017; 216 3515_CR11 JW Mellors (3515_CR46) 1996; 272 3515_CR12 L Malek (3515_CR49) 1994; 28 S Xu (3515_CR62) 2010; 14 RT Skerlj (3515_CR123) 2010; 53 LA Earl (3515_CR4) 2013; 21 RW Yucha (3515_CR139) 2017; 20 M Chang (3515_CR99) 2017; 97 E Corfec Le (3515_CR79) 1999; 39 IV Bassett (3515_CR94) 2015; 12 A Chaillon (3515_CR147) 2017; 92 JS Koopman (3515_CR92) 1997; 14 KP Delaney (3515_CR10) 2017; 44 P Grabarczyk (3515_CR76) 2013; 53 JPA Ioannidis (3515_CR127) 2001; 135 3515_CR26 3515_CR27 3515_CR28 T Bourlet (3515_CR41) 2013; 13 3515_CR22 3515_CR23 3515_CR24 3515_CR25 WS Stevens (3515_CR42) 2009; 47 3515_CR20 3515_CR21 LA Cozzi (3515_CR47) 1998; 12 J Ragoussis (3515_CR130) 2009; 10 B Mothe (3515_CR141) 2015; 70 KJ Bosman (3515_CR148) 2015; 5 VM Pierce (3515_CR88) 2011; 49 HA Duarte (3515_CR113) 2017; 216 A Dumoulin (3515_CR131) 2011; 49 RJ Simonds (3515_CR43) 1998; 12 P Cahn (3515_CR107) 2013; 382 G Zhang (3515_CR116) 2016; 54 S Pas (3515_CR16) 2010; 48 AR Margaritis (3515_CR73) 2007; 47 3515_CR37 MA Abbott (3515_CR48) 1988; 158 IV Jani (3515_CR100) 2016; 54 TD Ly (3515_CR8) 2004; 122 3515_CR38 3515_CR39 MG Robert (3515_CR33) 2003; 41 3515_CR34 3515_CR35 3515_CR36 M Brauer (3515_CR7) 2013; 189 3515_CR30 KMD Cock (3515_CR83) 2000; 283 M Rosas-Umbert (3515_CR145) 2017; 12 3515_CR32 W Stevens (3515_CR86) 2008; 2 V Soriano (3515_CR155) 2017; 19 RY Dodd (3515_CR69) 2015; 9 AF Susan (3515_CR65) 2013; 51 EO Johnson (3515_CR121) 2015; 10 M Drancourt (3515_CR97) 2016; 29 G Hütter (3515_CR159) 2015; 7 KJ Metzner (3515_CR114) 2011; 50 SH Eshleman (3515_CR31) 2004; 42 SA Galel (3515_CR15) 2018; 58 E Hamlyn (3515_CR68) 2010; 5 BG Brenner (3515_CR93) 2007; 195 JB Maria (3515_CR146) 2014; 88 M Mori (3515_CR129) 2014; 28 MC Strain (3515_CR150) 2013; 8 YC Tung (3515_CR54) 2015; 31 RB Jones (3515_CR138) 2016; 12 3515_CR2 3515_CR3 S Komninakis (3515_CR132) 2007; 40 3515_CR1 L Zhang (3515_CR60) 2017; 38 A Assal (3515_CR74) 2009; 49 3515_CR40 Y Zhao (3515_CR9) 2018; 56 F Canals (3515_CR85) 2018; 19 P Alvarez (3515_CR89) 2017; 81 K Laethem Van (3515_CR120) 2015; 14 W Schumacher (3515_CR52) 2007; 38 R Dubrow (3515_CR44) 2017; 75 Z Liu (3515_CR125) 2017; 7 M Schmidt (3515_CR17) 2009; 49 HE Lynch (3515_CR134) 2013; 979 T Elbeik (3515_CR59) 2014; 2 EG Martin (3515_CR95) 2013; 58 T Tsukamoto (3515_CR124) 2018; 32 G Hutter (3515_CR154) 2009; 360 B Vogelstein (3515_CR137) 1999; 96 3515_CR57 Y Ho (3515_CR152) 2013; 155 3515_CR58 RM Grant (3515_CR115) 2015; 29 V Shyamala (3515_CR70) 2015; 9 |
| References_xml | – reference: DumoulinAHirschHHReevaluating and optimizing polyomavirus BK and JC real-time PCR assays to detect rare sequence polymorphismsJ Clin Microbiol2011494138210.1128/JCM.02008-101:CAS:528:DC%2BC3MXhtFKrt7nM213255603122792 – reference: PasSRossenJWSchoenerDThamkeDPetterssonABabielRPerformance evaluation of the new Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 for quantification of human immunodeficiency virus type 1 RNAJ Clin Microbiol20104841195120010.1128/JCM.01832-091:CAS:528:DC%2BC3cXmt1Kgtbs%3D201642812849552 – reference: Human immunodeficiency virus, type 1 (HIV-1) REVERSE TRANSCRIPTION (RT) polymerase chain reaction (PCR) assay, https://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/ucm093501.htm – reference: D'AntoniMLPaulRHMitchellBIKohornLFischerLLefebvreEImproved cognitive performance and reduced monocyte activation in virally suppressed chronic HIV following dual CCR2 and CCR5 antagonismJ Acquir Immune Defic Syndr2018791110.1097/QAI.00000000000017701:CAS:528:DC%2BC1cXhsFSqs7zI – reference: WangZPanQGendronPZhuWGuoFCenSCRISPR/Cas9-derived mutations both inhibit HIV-1 replication and accelerate viral escapeCell Rep201615348148910.1016/j.celrep.2016.03.0421:CAS:528:DC%2BC28Xlsleltr8%3D27068471 – reference: Wiesmann F, Ehret R, Naeth G, Daumer M, Fuhrmann J, Kaiser R et al (2018) Multicenter evaluation of two next-generation HIV-1 quantitation assays, Aptima Quant Dx and Cobas 6800, in comparison to the RealTime HIV-1 reference assay. J Clin Microbiol 56(10) – reference: SkerljRTBridgerGJKallerAMceachernEJCrawfordJBZhouYDiscovery of novel small molecule orally bioavailable C-X-C chemokine receptor 4 antagonists that are potent inhibitors of T-tropic (X4) HIV-1 replicationJ Med Chem20105383376338810.1021/jm100073m1:CAS:528:DC%2BC3cXjs1Wrs7c%3D20297846 – reference: DelaneyKPWesolowskiLGOwenSMThe evolution of HIV testing continuesSex Transm Dis2017441274774910.1097/OLQ.000000000000073629140891 – reference: ChangMSteinmetzerKRaugiDNSmithRABaSSallFDetection and differentiation of HIV-2 using the point-of-care Alere q HIV-1/2 detect nucleic acid testJ Clin Virol201797222510.1016/j.jcv.2017.10.0131:CAS:528:DC%2BC2sXhslChsLjO290963895700839 – reference: DoddRYTransfusion-transmitted infections: testing strategies and residual riskIsbt Science20159115 – reference: GrabarczykPvan DrimmelenHKopaczAGdowskaJLiszewskiGPiotrowskiDHead-to-head comparison of two transcription-mediated amplification assay versions for detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1 in blood donorsTransfusion20135310 Pt 22512252410.1111/trf.121901:CAS:528:DC%2BC3sXhs1Cmu7jF23590145 – reference: AssalABarletVDeschaseauxMDupontIGallianPGuittonCComparison of the analytical and operational performance of two viral nucleic acid test blood screening systems: Procleix Tigris and cobas s 201Transfusion200949228930010.1111/j.1537-2995.2008.01965.x19000230 – reference: BrauerMDe VilliersJCMayaphiSHEvaluation of the determine fourth generation HIV rapid assayJ Virol Methods2013189118018310.1016/j.jviromet.2013.01.0171:CAS:528:DC%2BC3sXjtFWgurY%3D23391823 – reference: SlomaCRGermerJJGeradsTMMandrekarJNMitchellPSYaoJDComparison of the Abbott realtime human immunodeficiency virus type 1 (HIV-1) assay to the Cobas AmpliPrep/Cobas TaqMan HIV-1 test: workflow, reliability, and direct costsJ Clin Microbiol200947488989510.1128/JCM.02231-081:CAS:528:DC%2BD1MXlvVamsL4%3D191938372668302 – reference: StevensWShermanGDowningRParsonsLMOuCYCrowleySRole of the laboratory in ensuring global access to ARV treatment for HIV-infected children: consensus statement on the performance of laboratory assays for early infant diagnosisOpen AIDS J20082172510.2174/18746136008020100171:STN:280:DC%2BD1MfhsV2gtA%3D%3D189236962556199 – reference: HancockGMorónlópezSKopycinskiJPuertasMCGiannoulatouERoseAEvaluation of the immunogenicity and impact on the latent HIV-1 reservoir of a conserved region vaccine, MVA.HIVconsv, in antiretroviral therapy-treated subjectsJournal of the International Aids Society2017201110.7448/IAS.20.1.21171 – reference: NGI UltraQual Multiplex PCR Assay for HCV, HIV-1, HIV-2 and HBV, https://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/UCM609997.pdf – reference: XuSSongANieJLiXWangYPerformance of NucliSens HIV-1 EasyQ Version 2.0 compared with six commercially available quantitative nucleic acid assays for detection of HIV-1 in ChinaMol Diagn Ther201014530510.1007/BF032563861:CAS:528:DC%2BC3MXis1ahtw%3D%3D21053996 – reference: MartinEGSalaruGMohammedDCoombsRWPaulSMCadoffEMFinding those at risk: acute HIV infection in Newark, NJJ Clin Virol201358E24E2810.1016/j.jcv.2013.07.016239539414266376 – reference: CanalsFMasiaMGutierrezFDevelopments in early diagnosis and therapy of HIV infection in newbornsExpert Opin Pharmacother2018191132510.1080/14656566.2017.136318028764578 – reference: UltraQual HIV-1 RT-PCR Assay, https://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/ucm172937.htm – reference: TungYCKeLYLuPLLinKHLeeSCLinYYComparison of the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 test V1.0 with V2.0 in HIV-1 viral load quantificationKaohsiung J Med Sci201531418819310.1016/j.kjms.2014.12.01025835274 – reference: SchmidtMKornKNublingCMChudyMKressJHorstHAFirst transmission of human immunodeficiency virus type 1 by a cellular blood product after mandatory nucleic acid screening in GermanyTransfusion20094991836184410.1111/j.1537-2995.2009.02203.x1:CAS:528:DC%2BD1MXht1WnsLzO19453990 – reference: TouloumiGPantazisNKarafoulidouAMandalakiTGoedertJJKostrikisLGChanges in T cell receptor excision DNA circle (TREC) levels in HIV type 1-infected subjects pre- and post-highly active antiretroviral therapyAids Research & Human Retroviruses2004201475410.1089/0889222043227494951:CAS:528:DC%2BD2cXpsFShuw%3D%3D – reference: (2018) HIV/AIDS Fact sheets, http://www.who.int/en/news-room/fact-sheets/detail/hiv-aids – reference: EngelNPantPNQualitative research on point-of-care testing strategies and programs for HIVExpert Rev Mol Diagn20151517110.1586/14737159.2015.9605181:CAS:528:DC%2BC2cXitFaqtb3L25267607 – reference: RothWKWeberMSeifriedEFeasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank settingLancet1999353915035910.1016/S0140-6736(98)06318-11:CAS:528:DyaK1MXht1Wgsbs%3D9950441 – reference: Branson B, Owen SM, Bennett B, Werner BG, Pentella MA, Wesolowski LG (2014) Laboratory testing for the diagnosis of HIV infection: updated recommendations. Algorithms – reference: CahnPPozniakALMingroneHShuldyakovABritesCAndrade-VillanuevaJFDolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING studyLancet2013382989370070810.1016/S0140-6736(13)61221-01:CAS:528:DC%2BC3sXhtVKrur7I23830355 – reference: EshlemanSHJohnHPriscillaSCunninghamSPBirgitDCatherineBPerformance of the Celera Diagnostics ViroSeq HIV-1 Genotyping System for sequence-based analysis of diverse human immunodeficiency virus type 1 strainsJ Clin Microbiol2004426271110.1128/JCM.42.6.2711-2717.20041:CAS:528:DC%2BD2cXlslals78%3D15184457427844 – reference: OuC-YFiscusSEllenbergerDParekhBKorhonenCNkengasongJEarly diagnosis of HIV infection in the breastfed infantAdv Exp Med Biol2012743743516510.1007/978-1-4614-2251-8_422454341 – reference: BrennerBGRogerMRoutyJPMoisiDNtemgwaMMatteCHigh rates of forward transmission events after acute/early HIV-1 infectionJ Infect Dis2007195795195910.1086/5120881:CAS:528:DC%2BD2sXksVOlsLc%3D17330784 – reference: JaniIVMeggiBVubilASitoeNEBhattNTobaiwaOEvaluation of the whole-blood Alere Q NAT point-of-care RNA assay for HIV-1 viral load monitoring in a primary health care setting in MozambiqueJ Clin Microbiol20165482104210810.1128/JCM.00362-161:CAS:528:DC%2BC2sXhsFyjsr%2FI272524594963486 – reference: COBAS TaqScreen MPX Test, https://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloo-dProducts/ApprovedProducts/LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/UCM176443.pdf – reference: cobas HIV-1 Quantitative nucleic acid test for use on the cobas 6800/8800 Systems, https://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/PremarketApprovalsPMAs/UCM478438.pdf – reference: DrancourtMMichellepageABoyerSRaoultDThe point-of-care laboratory in clinical microbiologyClin Microbiol Rev201629342910.1128/CMR.00090-15270295934861988 – reference: StelzlEProllJBizonBNiklasNDanzerMHacklCHuman immunodeficiency virus type 1 drug resistance testing: evaluation of a new ultra-deep sequencing-based protocol and comparison with the TRUGENE HIV-1 genotyping kitJ Virol Methods20111781–2949710.1016/j.jviromet.2011.08.0201:CAS:528:DC%2BC3MXhtlKrtr7J21907239 – reference: McLarenPJPulitSLGurdasaniDBarthaISheaPRPomillaCEvaluating the impact of functional genetic variation on HIV-1 controlJ Infect Dis201721691063106910.1093/infdis/jix4701:CAS:528:DC%2BC1cXisVCnsrbI289687555853944 – reference: ZhangLJinCJiangZTangTJiangYPanPLComparison of commercial HIV-1 viral load tests by using proficiency test results in China, 2013–2015Zhonghua Liu Xing Bing Xue Za Zhi2017389123112351:STN:280:DC%2BC1cbos1WitQ%3D%3D28910938 – reference: WestenGJPVHendriksAWegnerJKIjzermanAPVlijmenHWTVBenderASignificantly improved HIV inhibitor efficacy prediction employing proteochemometric models generated from antivirogram dataPLoS Comput Biol201392(2013-2-21)e100289910.1371/journal.pcbi.10028991:CAS:528:DC%2BC3sXkt1Wms7k%3D234369853578754 – reference: ThiamMDiop-NdiayeHKebeKVidalNDiakhate-LôRDiouaraAAPerformance of the ViroSeq HIV-1 genotyping system V2.0 on HIV-1 strains circulating in SenegalJ Virol Methods20131881–29710310.1016/j.jviromet.2012.11.0441:CAS:528:DC%2BC3sXktFWqs7g%3D23266258 – reference: ViroSeq HIV-1 Genotyping System, https://www.molecular.abbott/us/en/products/infectious-disease/viroseq-hiv-1-genotyping-system – reference: BassettIVChettySGiddyJReddySBishopKLuZScreening for acute HIV infection in South Africa: finding acute and chronic diseaseHIV Med2015121465310.1111/j.1468-1293.2010.00850.x – reference: Aptima HIV-1 Quant Assay, https://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/PremarketApprovalsPMAs/UCM534609.pdf – reference: PatteryTVerlindenYDe WolfHNauwelaersDVan BaelenKVan HoutteMDevelopment and performance of conventional HIV-1 phenotyping (Antivirogram(R)) and genotype-based calculated phenotyping assay (virco(R)TYPE HIV-1) on protease and reverse transcriptase genes to evaluate drug resistanceIntervirology201255213814610.1159/0003320131:CAS:528:DC%2BC38Xhs1Kgsb4%3D22286884 – reference: LiuZChenSJinXWangQYangKLiCGenome editing of the HIV co-receptors CCR5 and CXCR4 by CRISPR-Cas9 protects CD4 + T cells from HIV-1 infectionCell Biosci2017714710.1186/s13578-017-0174-21:CAS:528:DC%2BC1cXltlKltbk%3D289047455591563 – reference: HornTChangCAUrdeaMSChemical synthesis and characterization of branched oligodeoxyribonucleotides (bDNA) for use as signal amplifiers in nucleic acid quantification assaysNucleic Acids Res199725234842484910.1093/nar/25.23.48421:CAS:528:DyaK1cXhslGltw%3D%3D9365266147109 – reference: (2010) WHO Guidelines Approved by the Guidelines Review Committee. WHO Recommendations on the Diagnosis of HIV Infection in Infants and Children. World Health Organization World Health Organization., Geneva – reference: MotheBClimentNPlanaMRosàMLuisJNezJSafety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1J Antimicrob Chemother2015706183318421:CAS:528:DC%2BC2MXhsFaiu7bF25724985 – reference: CockKMDFowlerMGMercierEVincenziIDSabaJHoffEPrevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practiceJama200028391175118210.1001/jama.283.9.117510703780 – reference: SchumacherWFrickEKauselmannMMaier-HoyleVvan der VlietRBabielRFully automated quantification of human immunodeficiency virus (HIV) type 1 RNA in human plasma by the COBAS AmpliPrep/COBAS TaqMan systemJ Clin Virol200738430431210.1016/j.jcv.2006.12.0221:CAS:528:DC%2BD2sXjtFKjtL4%3D17329164 – reference: ElbeikTLoftusRABeringerSHealth care industries perspective of viral load assays: the VERSANT HIV-1 RNA 3.0 assayExpert Rev Mol Diagn20142327528510.1586/14737159.2.3.275 – reference: Quinones-MateuMEAvilaSReyes-TeranGMartinezMADeep sequencing: becoming a critical tool in clinical virologyJ Clin Virol201461191910.1016/j.jcv.2014.06.013249984244119849 – reference: cobas TaqScreen MPX Test, version 2.0 for use with the cobas s 201 system, https://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/UCM427750.pdf – reference: BourletTMemmiMSaoudinHPozzettoBMolecular HIV screeningExpert Rev Mol Diagn201313769370510.1586/14737159.2013.8297031:CAS:528:DC%2BC3sXhsFSmsbvK24063397 – reference: SusanAFTakeshaMJulieAENWilliamCMValidation of the gen-probe Aptima qualitative HIV-1 RNA assay for diagnosis of human immunodeficiency virus infection in infantsJ Clin Microbiol201351124137414010.1128/JCM.01525-131:CAS:528:DC%2BC2cXhsVGks7rL – reference: IoannidisJPARosenbergPSGoedertJJAshtonLJBenfieldTLBuchbinderSPEffects of CCR5-Δ 32, CCR2-64I, and SDF-1 3′a alleles on HIV-1 disease progression: an international meta-analysis of individual-patient dataAnn Intern Med2001135978279510.7326/0003-4819-135-9-200111060-000081:CAS:528:DC%2BD3MXotlyks7Y%3D11694103 – reference: DevadasKBiswasSHaleyurgirisettyMWoodORagupathyVLeeSAnalysis of host gene expression profile in HIV-1 and HIV-2 infected T-cellsPLoS One2016111e014742110.1371/journal.pone.01474211:CAS:528:DC%2BC28Xns1Gmsro%3D268213234731573 – reference: ParaschivSOteleaDBaicusCTinischiMCostacheMNeagaENucleoside reverse transcriptase inhibitor resistance mutations in subtype F1 strains isolated from heavily treated adolescents in RomaniaInt J Infect Dis2009131818910.1016/j.ijid.2008.03.0321:CAS:528:DC%2BD1MXisVGqtrY%3D18632295 – reference: Rosas-UmbertMMotheBNoguera-JulianMBellidoRPuertasMCCarrilloJVirological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-BPLoS One2017129e018492910.1371/journal.pone.01849291:CAS:528:DC%2BC1cXnvFGjsL0%3D289539215617163 – reference: EarlLALifsonJDSubramaniamSCatching HIV ‘in the act’ with 3D electron microscopyTrends Microbiol201321839740410.1016/j.tim.2013.06.0041:CAS:528:DC%2BC3sXhtV2rtrzM238503733773172 – reference: TsukamotoTTranscriptional gene silencing limits CXCR4-associated depletion of bone marrow CD34+ cells in HIV-1 infectionAids201832131737174710.1097/QAD.00000000000018821:CAS:528:DC%2BC1cXhtlOktLfL29762163 – reference: (2014) Laboratory testing for the diagnosis of hiv infection updated recommendations, https://stacks.cdc.gov/view/cdc/23447 – reference: ZhuWLeiRDuffYLLiJGuoFWainbergMAThe CRISPR/Cas9 system inactivates latent HIV-1 proviral DNARetrovirology20151212210.1186/s12977-015-0150-z1:CAS:528:DC%2BC2MXmsFGgsLc%3D258084494359768 – reference: BransonBMSteklerJDDetection of acute HIV infection: we can’t close the windowJ Infect Dis2012205452152410.1093/infdis/jir79322207652 – reference: MargaritisARBrownSMSeedCRKielyPD'AgostinoBKellerAJComparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNATransfusion200747101783179310.1111/j.1537-2995.2007.01343.x1:CAS:528:DC%2BD2sXht1elsrvM17880602 – reference: COBAS AmpliPrep/COBAS TaqMan HIV-1 Test, 48 Tests; COBAS AmpliPrep/COBAS TaqMan Wash Reagent, 5.1 L, https://www.fda.gov/downloads/ BiologicsBloodVaccines/BloodBloodProducts/Approv-edProducts/PremarketApprovalsPMAs/UCM092878.pdf – reference: ZulfiqarHFJavedASumbalAfrozeBAliQAkbarKHIV diagnosis and treatment through advanced technologiesFront Public Health201753210.3389/fpubh.2017.00032283263045339269 – reference: MoriMWichukchindaNMiyaharaRRojanawiwatAPathipvanichPMaekawaTHLA-B*35: 05 is a protective allele with a unique structure among HIV-1 CRF01_AE-infected Thais, in whom the B*57 frequency is lowAids201428795996710.1097/QAD.00000000000002061:CAS:528:DC%2BC2cXlsF2htrY%3D24566094 – reference: ChaillonAGianellaSLadaSMPerez-SantiagoJJordanPIgnacioCSize, composition, and evolution of HIV DNA populations during early antiretroviral therapy and intensification with MaravirocJ Virol2017923JVI.01589JVI.0151710.1128/JVI.01589-17 – reference: StahlTBöhmeMUKrögerNFehseBDigital PCR to assess hematopoietic chimerism after allogeneic stem cell transplantationExp Hematol2015436462468.e46110.1016/j.exphem.2015.02.0061:CAS:528:DC%2BC2MXns1Oru7s%3D2579552325795523 – reference: BosmanKJNijhuisMvan HamPMWensingAMVervischKVandekerckhoveLComparison of digital PCR platforms and semi-nested qPCR as a tool to determine the size of the HIV reservoirSci Rep2015521381110.1038/srep138111:STN:280:DC%2BC283gs1emsQ%3D%3D263505064563360 – reference: MalekLSooknananRComptonJNucleic acid sequence-based amplification (NASBA)Methods Mol Biol199428282531:CAS:528:DyaK2cXhsFCqurw%3D7509695 – reference: KornKWeissbrichBHenke-GendoCHeimAJauerCMTaylorNSingle-point mutations causing more than 100-fold underestimation of human immunodeficiency virus type 1 (HIV-1) load with the Cobas TaqMan HIV-1 real-time PCR assayJ Clin Microbiol20094741238124010.1128/JCM.02204-081:CAS:528:DC%2BD1MXlvVamtb8%3D191938392668364 – reference: MourezTDelaugerreCVrayMLemeeVSimonFPlantierJCComparison of the bioMerieux NucliSENS EasyQ HIV-1 V2.0-HIV-1 RNA quantification assay versus Abbott RealTime HIV-1 and Roche Cobas TaqMan HIV-1 V2.0 on current epidemic HIV-1 variantsJ Clin Virol201571768110.1016/j.jcv.2015.08.0071:CAS:528:DC%2BC2MXhtlKksr7E26318912 – reference: JuliaDNienkeVTendaiMBregjeDBAOttoSAHazenbergMDReconciling longitudinal naive T-cell and TREC dynamics during HIV-1 infectionPLoS One2016113e015251310.1371/journal.pone.01525131:CAS:528:DC%2BC28Xht1amt7jE – reference: HamlynEJonesVPorterKFidlerSAntiretroviral treatment of primary HIV infection to reduce onward transmissionCurr Opin HIV AIDS20105428329010.1097/COH.0b013e32833a6b1120543602 – reference: MiguelesSAConnorsMLong-term nonprogressive disease among untreated HIV-infected individuals: clinical implications of understanding immune control of HIVJama2010304219420110.1001/jama.2010.9251:CAS:528:DC%2BC3cXovFGgsL0%3D20628133 – reference: KomninakisSFukumoriLAlcaldeRCortinaMAbdalaLBritoATechniques used to identify the Brazilian variant of HIV-1 subtype BBraz J Med Biol Res200740330110.1590/S0100-879X20070003000031:CAS:528:DC%2BD2sXksVCrt7o%3D17334525 – reference: MendozaDJohnsonSAPetersonBANatarajanVSalgadoMDewarRLComprehensive analysis of unique cases with extraordinary control over HIV replicationBlood2012119204645465510.1182/blood-2011-10-3819961:CAS:528:DC%2BC38XnsVKhuro%3D224903323367872 – reference: DuarteHAPanpradistNBeckIALutzBLaiJKanthulaRMCurrent status of point-of-care testing for human immunodeficiency virus drug resistanceJ Infect Dis2017216suppl_9S824s82810.1093/infdis/jix4131:CAS:528:DC%2BC1cXisVCns7jF290406215853236 – reference: GrantRMLieglerTDefechereuxPKashubaADTaylorDAbdelmohsenMDrug resistance and plasma viral RNA level after ineffective use of oral pre-exposure prophylaxis in womenAids201529333110.1097/QAD.00000000000005561:CAS:528:DC%2BC2MXisl2ntr4%3D25503265 – reference: (2016) BioMerieux SA alerts customers about potential inaccurate test results when using NucliSENS® easyMAG® magnetic silica for nucleic acid extraction, https://www.fda.gov/MedicalDevice-s/Safety/ListofRecalls/ucm516437.htm – reference: HaJParkYKimHSEvaluation of clinical sensitivity and specificity of hepatitis B virus (HBV), hepatitis C virus, and human immunodeficiency Virus-1 by cobas MPX: detection of occult HBV infection in an HBV-endemic areaJ Clin Virol201796606310.1016/j.jcv.2017.09.0101:CAS:528:DC%2BC2sXhsF2gsrrP28982042 – reference: HütterGBodorJLedgerSBoydMMillingtonMTsieMCCR5 targeted cell therapy for HIV and prevention of viral escapeViruses2015784186420310.3390/v70828161:CAS:528:DC%2BC2MXhslOqt77N262259914576177 – reference: AssalABarletVDeschaseauxMDupontIGallianPGuittonCSensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panelsTransfusion200949230131010.1111/j.1537-2995.2008.01966.x19389212 – reference: cobas MPX Test, for use on the cobas 6800/8800 Systems, https://www.fda.gov/downloads/Biol-ogicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/UCM614913.pdf – reference: BaumeisterMAZhangNBeasHBrooksJRCancholaJACosenzaCA sensitive branched DNA HIV-1 signal amplification viral load assay with single day turnaroundPLoS One201273e3329510.1371/journal.pone.00332951:CAS:528:DC%2BC38Xlt1CntrY%3D224793813314011 – reference: MariaJBEnriqueM-GFlorenciaPZhengyuOHongSJonathanZLLong-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cellsJ Virol20148817100561006510.1128/JVI.01046-141:CAS:528:DC%2BC2cXhs1amtbfF – reference: JohnsonEOHancockDBGaddisNCLevyJLPageGNovakSPNovel genetic locus implicated for HIV-1 acquisition with putative regulatory links to HIV replication and infectivity: a genome-wide association studyPLoS One2015103e011814910.1371/journal.pone.01181491:CAS:528:DC%2BC2MXhslOqurvF257862244364715 – reference: VERSANT HIV-1 RNA 3.0 Assay (bDNA), https://www.fda.gov/downloads/BiologicsBloodVaccines-/BloodBloodProducts/ApprovedProducts/PremarketApprovalsPMAs/UCM091276.pdf – reference: DubrowRQinLLinHHernandez-RamirezRUNeugebauerRSLeydenWAssociation of CD4+ T-cell count, HIV-1 RNA viral load, and antiretroviral therapy with Kaposi sarcoma risk among HIV-infected persons in the United States and CanadaJ Acquir Immune Defic Syndr201775438239010.1097/QAI.00000000000013941:CAS:528:DC%2BC2sXhtVKqur%2FM283948555490794 – reference: LeliePNvan DrimmelenHACuypersHTBestSJStramerSLHylandCSensitivity of HCV RNA and HIV RNA blood screening assaysTransfusion201042552753610.1046/j.1537-2995.2002.00101.x – reference: Van LaethemKBeuselinckKVan DoorenSDe ClercqEDesmyterJVandammeAMDiagnosis of human immunodeficiency virus infection by a polymerase chain reaction assay evaluated in patients harbouring strains of diverse geographical originJ Virol Methods199870215316610.1016/S0166-0934(97)00178-X9562409 – reference: RutsaertSBosmanKTrypsteenWNijhuisMVandekerckhoveLDigital PCR as a tool to measure HIV persistenceRetrovirology20181511610.1186/s12977-018-0399-01:CAS:528:DC%2BC1MXjtlKnsrg%3D293786005789538 – reference: ManakMMHackHRNairSVWorlockAMaliaJAPeelSAEvaluation of Hologic Aptima HIV-1 Quant Dx assay on the Panther System on HIV subtypesJ Clin Microbiol201654102575258110.1128/JCM.01350-161:CAS:528:DC%2BC1cXhtVyqtrY%3D275108295035401 – reference: APTIMA HIV-1 RNA Qualitative Assay, https://www.fda.gov/downloads/BiologicsBloodVaccines-/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/UCM149927.pdf – reference: AbbottMAPoieszBJByrneBCKwokSSninskyJJEhrlichGDEnzymatic gene amplification: qualitative and quantitative methods for detecting proviral DNA amplified in vitroJ Infect Dis198815861158116910.1093/infdis/158.6.11581:CAS:528:DyaL1MXhvVylsL0%3D3198934 – reference: StevensWSNobleLBerrieLSarangSScottLEUltra-high-throughput, automated nucleic acid detection of human immunodeficiency virus (HIV) for infant infection diagnosis using the Gen-Probe Aptima HIV-1 screening assayJ Clin Microbiol20094782465246910.1128/JCM.00317-09194742662725647 – reference: AlvarezPPrietoLMartinLObiangJAvedilloPVargasAEvaluation of four commercial virological assays for early infant HIV-1 diagnosis using dried blood specimensPediatr Res2017811–1808710.1038/pr.2016.18327653084 – reference: Complete list of donor screening assays for infectious agents and HIV diagnostic assays, https://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/ucm080466.htm#HIV1_NucleicAcid_Assays – reference: HeimAEvaluation of the Procleix Ultrio Elite Assay and the Panther-System for individual NAT screening of blood, hematopoietic stem cell, tissue and organ donorsTransfus Med Hemother201643317718210.1159/000446217274030894924462 – reference: Le CorfecELe PontFTuckwellHCRouziouxCCostagliolaDDirect HIV testing in blood donations: variation of the yield with detection threshold and pool sizeTransfusion199939101141114410.1046/j.1537-2995.1999.39101141.x10532610 – reference: Mayers DL, Baxter JD (2017) Clinical implications of HIV-1 drug resistance. In: Mayers DL, Sobel JD, Ouellette M, Kaye KS, Marchaim D (eds) Antimicrobial drug resistance: clinical and epidemiological aspects, Volume 2. Springer International Publishing, Cham, pp 1213–1225 – reference: ShyamalaVNucleic acid technology (NAT) testing for blood screening: impact of individual donation and Mini Pool-NAT testing on analytical sensitivity, screening sensitivity and clinical sensitivityIsbt Science20159231532410.1111/voxs.121061:CAS:528:DC%2BC2cXitVCisb7P – reference: Clutter DS, Rojas Sanchez P, Rhee SY, Shafer RW (2016) Genetic variability of HIV-1 for drug resistance assay development. Viruses 8(2) – reference: PierceVMNeideBHodinkaRLEvaluation of the Gen-Probe Aptima HIV-1 RNA qualitative assay as an alternative to Western blot analysis for confirmation of HIV infectionJ Clin Microbiol20114941642164510.1128/JCM.02183-101:CAS:528:DC%2BC3MXhtFKrtLrP213460523122829 – reference: GrabarczykPKoppelmanMBolandFSauledaSFabraCCambieGInclusion of human immunodeficiency virus type 2 (HIV-2) in a multiplex transcription-mediated amplification assay does not affect detection of HIV-1 and hepatitis B and C virus genotypes: a multicenter performance evaluation studyTransfusion20155592246225510.1111/trf.131931:CAS:528:DC%2BC2MXhsFGit7fI26103564 – reference: LuzuriagaKMofensonLMChallenges in the elimination of pediatric HIV-1 infectionN Engl J Med2016374876177010.1056/NEJMra15052561:CAS:528:DC%2BC28XhtFGqtr7L26933850 – reference: HoYShanLHosmane NinaNWangJLaskey SarahBRosenbloom DanielISReplication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cureCell2013155354055110.1016/j.cell.2013.09.0201:CAS:528:DC%2BC3sXhs1yrurrI242430143896327 – reference: MccoyLEWeissRANeutralizing antibodies to HIV-1 induced by immunizationJ Exp Med2013210220922310.1084/jem.201218271:CAS:528:DC%2BC3sXisV2qt7g%3D234015703570100 – reference: HsiaoNYDunningLKroonMMyerLLaboratory evaluation of the Alere q point-of-care system for early infant HIV diagnosisPLoS One2016113e015267210.1371/journal.pone.01526721:CAS:528:DC%2BC28XhtVOlsrnO270320944816318 – reference: SorianoVHot news: gene therapy with CRISPR/Cas9 coming to age for HIV cureAIDS Rev201719316717229019352 – reference: RagoussisJGenotyping technologies for genetic researchAnnu Rev Genomics Hum Genet200910111713310.1146/annurev-genom-082908-1501161:CAS:528:DC%2BD1MXht12qsrvN19453250 – reference: GalelSASimonTLWilliamsonPCAuBuchonJPWaxmanDAEricksonYSensitivity and specificity of a new automated system for the detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus nucleic acid in blood and plasma donationsTransfusion201858364965910.1111/trf.144571:CAS:528:DC%2BC1cXks1yhsbY%3D29250788 – reference: VogelsteinBKinzlerKWDigital PCRProc Natl Acad Sci U S A199996169236924110.1073/pnas.96.16.92361:CAS:528:DyaK1MXltVequrY%3D1043092617763 – reference: LyTDLapercheSBrennanCVallariAEbelAHuntJEvaluation of the sensitivity and specificity of six HIV combined p24 antigen and antibody assaysJ Virol Methods2004122218519410.1016/j.jviromet.2004.08.0181:CAS:528:DC%2BD2cXpslOksLs%3D15542143 – reference: MüllerBNüblingCMKressJRothWKDe ZoltSPichlLHow safe is safe: new human immunodeficiency virus type 1 variants missed by nucleic acid testingTransfusion20135310pt22422243010.1111/trf.122981:CAS:528:DC%2BC3sXhs1Cmu7vF23782012 – reference: UNAIDS DATA 2017 http://www.unaids.org/en/resources/documents/2017/2017_data_book – reference: (2018) Advantages and disadvantages of FDA-approved HIV assays used for screening, by test category, https://www.cdc.gov/hiv/pdf/testing/hiv-tests-advantages-disadvantages_1.pdf – reference: OuCYKwokSMitchellSWMackDHSninskyJJKrebsJWDNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cellsScience1988239483729529710.1126/science.33367841:CAS:528:DyaL1cXht1Ors70%3D3336784 – reference: Murtagh M (2013) HIV / AIDS diagnostic technology landscape. 3rd edition – reference: StrainMCLadaSMLuongTRoughtSEGianellaSTerryVHHighly precise measurement of HIV DNA by droplet digital PCRPLoS One201384e5594310.1371/journal.pone.00559431:CAS:528:DC%2BC3sXmtFWrtLY%3D235731833616050 – reference: MellorsJWRinaldoCRJrGuptaPWhiteRMToddJAKingsleyLAPrognosis in HIV-1 infection predicted by the quantity of virus in plasmaScience199627252651167117010.1126/science.272.5265.11671:CAS:528:DyaK28XjtF2nsrg%3D8638160 – reference: GooLJalalianlechakZRichardsonBAOverbaughJA combination of broadly neutralizing HIV-1 monoclonal antibodies targeting distinct epitopes effectively neutralizes variants found in early infectionJ Virol20128619108571086110.1128/JVI.01414-121:CAS:528:DC%2BC38XhtlOmtbjI228372043457273 – reference: Abbott RealTime HIV-1 Amplification Reagent Kit, Abbott RealTime HIV-1 Calibrator Kit, Abbott RealTime HIV-1 Control Kit, https://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/PremarketApprovalsPMAs/UCM091193.pdf – reference: ChudyMWeber-SchehlMPichlLJorkCKressJHeidenMBlood screening nucleic acid amplification tests for human immunodeficiency virus type 1 may require two different amplification targetsTransfusion201252243143910.1111/j.1537-2995.2011.03281.x1:CAS:528:DC%2BC38XktFKhs7g%3D21810100 – reference: TsaiHCChenITLeeSSChenYSHIV-1 genotypic drug resistance in patients with virological failure to single-tablet antiretroviral regimens in southern TaiwanInfection & Drug Resistance201811106110.2147/IDR.S165811 – reference: MohamedSPenarandaGGonzalezDCamusCKhiriHBoulméRClinical impact of ultra deep versus Sanger sequencing detection of minority mutations on HIV-1 drug resistance genotype interpretation after virological failureAids201414S211 – reference: GomesPPalmaACCabanasJAbecasisACarvalhoAPZiermannRComparison of the COBAS TAQMAN HIV-1 HPS with VERSANT HIV-1 RNA 3.0 assay (bDNA) for plasma RNA quantitation in different HIV-1 subtypesJ Virol Methods2006135222322810.1016/j.jviromet.2006.03.0181:CAS:528:DC%2BD28XlvFGhtrw%3D16675034 – reference: HenrichTJGallienSLiJZPereyraFKuritzkesDRLow-level detection and quantitation of cellular HIV-1 DNA and 2-LTR circles using droplet digital PCRJ Virol Methods20121861–2687210.1016/j.jviromet.2012.08.0191:CAS:528:DC%2BC38Xhs1CjsLbL229745263517891 – reference: MekueMLCHélènePAngéliqueNMDonatoKDieuLJDFrançois-XavierMKLETTER TO THE EDITOR Performance of the ViroSeq® HIV-1 genotyping system V2.0 in Central AfricaOpen Aids Journal20159191310.2174/1874613601509010009 – reference: MetznerKJRauchPBraunPKnechtenHEhretRKornKPrevalence of key resistance mutations K65R, K103N, and M184V as minority HIV-1 variants in chronically HIV-1 infected, treatment-naive patientsJ Clin Virol201150215616110.1016/j.jcv.2010.10.0011:CAS:528:DC%2BC3MXht1Cns7w%3D21056001 – reference: HutterGNowakDMossnerMGanepolaSMussigAAllersKLong-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantationN Engl J Med2009360769269810.1056/NEJMoa080290519213682 – reference: SimondsRJBrownTMTheaDMOrloffSLSteketeeRWLeeFKSensitivity and specificity of a qualitative RNA detection assay to diagnose HIV infection in young infants. Perinatal AIDS Collaborative Transmission StudyAids199812121545154910.1097/00002030-199812000-000181:CAS:528:DyaK1cXlvVCntrY%3D9727577 – reference: CeffaSLuhangaRAndreottiMBrambillaDErbaFJereHComparison of the Cepheid GeneXpert and Abbott M2000 HIV-1 real time molecular assays for monitoring HIV-1 viral load and detecting HIV-1 infectionJ Virol Methods2016229353910.1016/j.jviromet.2015.12.0071:CAS:528:DC%2BC2MXitV2jtbfN26709099 – reference: Procleix Ultrio Assay, https://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProd-ucts/ApprovedProducts/LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/UCM335285.pdf – reference: Loetscher P (2017) Performance evaluation of Cobas® HIV-1, a quantitative nucleic acid test for use on the Cobas® 6800/8800 systems. Journal of HIV and AIDS 3(1) – reference: PirontiAWalterHPfeiferNKnopsELübkeNBüchJDetermination of phenotypic resistance cutoffs from routine clinical dataJ Acquir Immune Defic Syndr2017745e129e13710.1097/QAI.0000000000001198277873395351752 – reference: JonesRBMuellerSO'ConnorRRimpelKSloanDDKarelDA subset of latency-reversing agents expose HIV-infected resting CD4+ T-cells to recognition by cytotoxic T-lymphocytesPLoS Pathog2016124e100554510.1371/journal.ppat.10055451:CAS:528:DC%2BC28XhtlGqs73E270826434833318 – reference: ZhangGCaiFde RiveraILZhouZZhangJNkengasongJSimultaneous detection of major drug resistance mutations of HIV-1 subtype B viruses from dried blood spot specimens by multiplex allele-specific assayJ Clin Microbiol201654122022210.1128/JCM.02833-151:CAS:528:DC%2BC28Xps1entLY%3D26560533 – reference: SamsonMLabbeOMollereauCVassartGParmentierMMolecular cloning and functional expression of a new human CC-chemokine receptor geneBiochemistry199635113362336710.1021/bi952950g1:CAS:528:DyaK28XhtlWit7k%3D8639485 – reference: COBAS AmpliScreen HIV-1 Test, https://www.fda.gov/downloads/BiologicsBloodVaccines/Blood-BloodProducts/ApprovedProducts/LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/UCM093531.pdf – reference: Procleix Ultrio Elite Assay, https://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBlood-Products/ApprovedProducts/LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/UCM606730.pdf – reference: ScottLGousNCarmonaSStevensWLaboratory evaluation of the Liat HIV Quant (IQuum) whole-blood and plasma HIV-1 viral load assays for point-of-care testing in South AfricaJ Clin Microbiol20155351616162110.1128/JCM.03325-14257407774400747 – reference: YuchaRWHobbsKSHanhauserEHoganLENievesWOzenMOHigh-throughput characterization of HIV-1 reservoir reactivation using a single-cell-in-droplet PCR assayEbiomedicine201720C21722910.1016/j.ebiom.2017.05.006285290335478213 – reference: ZhaoYGouYLiDWangTHuangXShiMPerformance evaluation of a new automated fourth-generation HIV Ag/Ab combination chemiluminescence immunoassayClin Chem Lab Med2018565e115e11710.1515/cclm-2017-09101:CAS:528:DC%2BC1cXntFWhtbo%3D29320363 – reference: Van LaethemKTheysKVandammeAMHIV-1 genotypic drug resistance testing: digging deep, reaching wide?Curr Opin Virol201514162310.1016/j.coviro.2015.06.0011:CAS:528:DC%2BC2MXhtVKmtrrM26114581 – reference: LynchHESempowskiGDMolecular measurement of T cell receptor excision circlesMethods Mol Biol201397997914710.1007/978-1-62703-290-2_121:CAS:528:DC%2BC3sXhs1Ols7fE233973943718036 – reference: RobertMGDanielRKVictoriaAJJohnWMJohnLSRonaldSAccuracy of the TRUGENE HIV-1 genotyping kitJ Clin Microbiol2003414158610.1128/JCM.41.4.1586-1593.20031:CAS:528:DC%2BD3sXjsVOnu7k%3D – reference: Procleix Ultrio Plus Assays, https://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBlood-Products/ApprovedProducts/LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/UCM092120.pdf – reference: Verheyen J, Thielen A, Lübke N, Dirks M, Widera M, Dittmer U, et al (2018) Rapid rebound of a preexisting CXCR4-tropic HIV variant after allogeneic transplantation with CCR5 delta32 homozygous stem cells. Clinical Infectious Diseases An Official Publication of the Infectious Diseases Society of America – reference: WeberBScreening of HIV infection: role of molecular and immunological assaysExpert Rev Mol Diagn20066339941110.1586/14737159.6.3.3991:CAS:528:DC%2BD28XmtlOhs7o%3D16706742 – reference: EmersonBPloughKDetection of acute HIV-1 infections utilizing NAAT technology in Dallas, TexasJ Clin Virol201358Suppl 1e48e5310.1016/j.jcv.2013.08.00523999031 – reference: KoopmanJSJacquezJAWelchGWSimonCPFoxmanBPollockSMThe role of early HIV infection in the spread of HIV through populationsJ Acquir Immune Defic Syndr Hum Retrovirol199714324925810.1097/00042560-199703010-000091:STN:280:DyaK2s3jt1ersA%3D%3D9117458 – reference: VianaIFTCoelhoDFPalmaMLNascimentoEJMGuGLimaLFODetection of IgG3 antibodies specific to the human immunodeficiency virus type 1 (HIV-1) p24 protein as marker for recently acquired infectionEpidemiol Infect2018146101293130010.1017/S09502688180012181:CAS:528:DC%2BC1cXhtlyku77P299254456062475 – reference: MayMTGompelsMDelpechVPorterKOrkinCKeggSImpact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapyAids20142881193120210.1097/QAD.0000000000000243245568694004637 – reference: CozziLAKatzensteinTLUllumHPhillipsANSkinhøjPGerstoftJThe relative prognostic value of plasma HIV RNA levels and CD4 lymphocyte counts in advanced HIV infectionAids199812131639164310.1097/00002030-199813000-00011 – reference: Roche Amplicor HIV-1 Monitor Test, https://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/PremarketApprovalsPMAs/UCM093317.pdf – ident: 3515_CR1 – volume: 20 start-page: 47 issue: 1 year: 2004 ident: 3515_CR136 publication-title: Aids Research & Human Retroviruses doi: 10.1089/088922204322749495 – ident: 3515_CR19 – volume: 54 start-page: 2104 issue: 8 year: 2016 ident: 3515_CR100 publication-title: J Clin Microbiol doi: 10.1128/JCM.00362-16 – volume: 20 start-page: 217 issue: C year: 2017 ident: 3515_CR139 publication-title: Ebiomedicine doi: 10.1016/j.ebiom.2017.05.006 – volume: 40 start-page: 301 issue: 3 year: 2007 ident: 3515_CR132 publication-title: Braz J Med Biol Res doi: 10.1590/S0100-879X2007000300003 – volume: 12 start-page: e0184929 issue: 9 year: 2017 ident: 3515_CR145 publication-title: PLoS One doi: 10.1371/journal.pone.0184929 – volume: 31 start-page: 188 issue: 4 year: 2015 ident: 3515_CR54 publication-title: Kaohsiung J Med Sci doi: 10.1016/j.kjms.2014.12.010 – volume: 135 start-page: 782 issue: 9 year: 2001 ident: 3515_CR127 publication-title: Ann Intern Med doi: 10.7326/0003-4819-135-9-200111060-00008 – ident: 3515_CR34 – volume: 155 start-page: 540 issue: 3 year: 2013 ident: 3515_CR152 publication-title: Cell doi: 10.1016/j.cell.2013.09.020 – ident: 3515_CR11 – volume: 10 start-page: 117 issue: 1 year: 2009 ident: 3515_CR130 publication-title: Annu Rev Genomics Hum Genet doi: 10.1146/annurev-genom-082908-150116 – volume: 11 start-page: e0147421 issue: 1 year: 2016 ident: 3515_CR133 publication-title: PLoS One doi: 10.1371/journal.pone.0147421 – volume: 189 start-page: 180 issue: 1 year: 2013 ident: 3515_CR7 publication-title: J Virol Methods doi: 10.1016/j.jviromet.2013.01.017 – volume: 38 start-page: 304 issue: 4 year: 2007 ident: 3515_CR52 publication-title: J Clin Virol doi: 10.1016/j.jcv.2006.12.022 – volume: 146 start-page: 1293 issue: 10 year: 2018 ident: 3515_CR5 publication-title: Epidemiol Infect doi: 10.1017/S0950268818001218 – volume: 35 start-page: 3362 issue: 11 year: 1996 ident: 3515_CR153 publication-title: Biochemistry doi: 10.1021/bi952950g – ident: 3515_CR25 – volume: 28 start-page: 1193 issue: 8 year: 2014 ident: 3515_CR45 publication-title: Aids doi: 10.1097/QAD.0000000000000243 – ident: 3515_CR63 – volume: 50 start-page: 156 issue: 2 year: 2011 ident: 3515_CR114 publication-title: J Clin Virol doi: 10.1016/j.jcv.2010.10.001 – volume: 8 start-page: e55943 issue: 4 year: 2013 ident: 3515_CR150 publication-title: PLoS One doi: 10.1371/journal.pone.0055943 – volume: 6 start-page: 399 issue: 3 year: 2006 ident: 3515_CR14 publication-title: Expert Rev Mol Diagn doi: 10.1586/14737159.6.3.399 – ident: 3515_CR40 – volume: 53 start-page: 2422 issue: 10pt2 year: 2013 ident: 3515_CR18 publication-title: Transfusion doi: 10.1111/trf.12298 – volume: 135 start-page: 223 issue: 2 year: 2006 ident: 3515_CR29 publication-title: J Virol Methods doi: 10.1016/j.jviromet.2006.03.018 – volume: 55 start-page: 2246 issue: 9 year: 2015 ident: 3515_CR77 publication-title: Transfusion doi: 10.1111/trf.13193 – volume: 2 start-page: 17 year: 2008 ident: 3515_CR86 publication-title: Open AIDS J doi: 10.2174/1874613600802010017 – volume: 7 start-page: 4186 issue: 8 year: 2015 ident: 3515_CR159 publication-title: Viruses doi: 10.3390/v7082816 – ident: 3515_CR39 – volume: 39 start-page: 1141 issue: 10 year: 1999 ident: 3515_CR79 publication-title: Transfusion doi: 10.1046/j.1537-2995.1999.39101141.x – volume: 44 start-page: 747 issue: 12 year: 2017 ident: 3515_CR10 publication-title: Sex Transm Dis doi: 10.1097/OLQ.0000000000000736 – volume: 79 start-page: 1 issue: 1 year: 2018 ident: 3515_CR126 publication-title: J Acquir Immune Defic Syndr doi: 10.1097/QAI.0000000000001770 – volume: 15 start-page: 481 issue: 3 year: 2016 ident: 3515_CR158 publication-title: Cell Rep doi: 10.1016/j.celrep.2016.03.042 – volume: 88 start-page: 10056 issue: 17 year: 2014 ident: 3515_CR146 publication-title: J Virol doi: 10.1128/JVI.01046-14 – volume: 49 start-page: 1642 issue: 4 year: 2011 ident: 3515_CR88 publication-title: J Clin Microbiol doi: 10.1128/JCM.02183-10 – volume: 9 start-page: 1 issue: 1 year: 2015 ident: 3515_CR69 publication-title: Isbt Science – volume: 19 start-page: 13 issue: 1 year: 2018 ident: 3515_CR85 publication-title: Expert Opin Pharmacother doi: 10.1080/14656566.2017.1363180 – volume: 272 start-page: 1167 issue: 5265 year: 1996 ident: 3515_CR46 publication-title: Science doi: 10.1126/science.272.5265.1167 – volume: 14 start-page: 249 issue: 3 year: 1997 ident: 3515_CR92 publication-title: J Acquir Immune Defic Syndr Hum Retrovirol doi: 10.1097/00042560-199703010-00009 – volume: 979 start-page: 147 issue: 979 year: 2013 ident: 3515_CR134 publication-title: Methods Mol Biol doi: 10.1007/978-1-62703-290-2_12 – ident: 3515_CR28 – volume: 374 start-page: 761 issue: 8 year: 2016 ident: 3515_CR84 publication-title: N Engl J Med doi: 10.1056/NEJMra1505256 – volume: 97 start-page: 22 year: 2017 ident: 3515_CR99 publication-title: J Clin Virol doi: 10.1016/j.jcv.2017.10.013 – volume: 47 start-page: 2465 issue: 8 year: 2009 ident: 3515_CR42 publication-title: J Clin Microbiol doi: 10.1128/JCM.00317-09 – volume: 49 start-page: 1836 issue: 9 year: 2009 ident: 3515_CR17 publication-title: Transfusion doi: 10.1111/j.1537-2995.2009.02203.x – volume: 19 start-page: 167 issue: 3 year: 2017 ident: 3515_CR155 publication-title: AIDS Rev – ident: 3515_CR20 – volume: 28 start-page: 959 issue: 7 year: 2014 ident: 3515_CR129 publication-title: Aids doi: 10.1097/QAD.0000000000000206 – ident: 3515_CR117 doi: 10.3390/v8020048 – volume: 49 start-page: 289 issue: 2 year: 2009 ident: 3515_CR74 publication-title: Transfusion doi: 10.1111/j.1537-2995.2008.01965.x – volume: 25 start-page: 4842 issue: 23 year: 1997 ident: 3515_CR50 publication-title: Nucleic Acids Res doi: 10.1093/nar/25.23.4842 – volume: 304 start-page: 194 issue: 2 year: 2010 ident: 3515_CR81 publication-title: Jama doi: 10.1001/jama.2010.925 – volume: 5 start-page: 13811 issue: 2 year: 2015 ident: 3515_CR148 publication-title: Sci Rep doi: 10.1038/srep13811 – volume: 353 start-page: 359 issue: 9150 year: 1999 ident: 3515_CR64 publication-title: Lancet doi: 10.1016/S0140-6736(98)06318-1 – ident: 3515_CR128 doi: 10.1093/cid/ciy565 – ident: 3515_CR32 – volume: 9 start-page: e1002899 issue: 2(2013-2-21) year: 2013 ident: 3515_CR108 publication-title: PLoS Comput Biol doi: 10.1371/journal.pcbi.1002899 – volume: 75 start-page: 382 issue: 4 year: 2017 ident: 3515_CR44 publication-title: J Acquir Immune Defic Syndr doi: 10.1097/QAI.0000000000001394 – volume: 53 start-page: 2512 issue: 10 Pt 2 year: 2013 ident: 3515_CR76 publication-title: Transfusion doi: 10.1111/trf.12190 – volume: 119 start-page: 4645 issue: 20 year: 2012 ident: 3515_CR82 publication-title: Blood doi: 10.1182/blood-2011-10-381996 – volume: 32 start-page: 1737 issue: 13 year: 2018 ident: 3515_CR124 publication-title: Aids doi: 10.1097/QAD.0000000000001882 – volume: 52 start-page: 431 issue: 2 year: 2012 ident: 3515_CR72 publication-title: Transfusion doi: 10.1111/j.1537-2995.2011.03281.x – volume: 11 start-page: 1061 year: 2018 ident: 3515_CR104 publication-title: Infection & Drug Resistance doi: 10.2147/IDR.S165811 – ident: 3515_CR23 – volume: 360 start-page: 692 issue: 7 year: 2009 ident: 3515_CR154 publication-title: N Engl J Med doi: 10.1056/NEJMoa0802905 – volume: 81 start-page: 80 issue: 1–1 year: 2017 ident: 3515_CR89 publication-title: Pediatr Res doi: 10.1038/pr.2016.183 – volume: 49 start-page: 301 issue: 2 year: 2009 ident: 3515_CR75 publication-title: Transfusion doi: 10.1111/j.1537-2995.2008.01966.x – volume: 56 start-page: e115 issue: 5 year: 2018 ident: 3515_CR9 publication-title: Clin Chem Lab Med doi: 10.1515/cclm-2017-0910 – volume: 15 start-page: 71 issue: 1 year: 2015 ident: 3515_CR98 publication-title: Expert Rev Mol Diagn doi: 10.1586/14737159.2015.960518 – volume: 55 start-page: 138 issue: 2 year: 2012 ident: 3515_CR106 publication-title: Intervirology doi: 10.1159/000332013 – volume: 20 start-page: 1 issue: 1 year: 2017 ident: 3515_CR140 publication-title: Journal of the International Aids Society doi: 10.7448/IAS.20.1.21171 – volume: 13 start-page: 81 issue: 1 year: 2009 ident: 3515_CR111 publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2008.03.032 – volume: 47 start-page: 1238 issue: 4 year: 2009 ident: 3515_CR53 publication-title: J Clin Microbiol doi: 10.1128/JCM.02204-08 – volume: 12 start-page: 1639 issue: 13 year: 1998 ident: 3515_CR47 publication-title: Aids doi: 10.1097/00002030-199813000-00011 – ident: 3515_CR37 – volume: 210 start-page: 209 issue: 2 year: 2013 ident: 3515_CR143 publication-title: J Exp Med doi: 10.1084/jem.20121827 – volume: 178 start-page: 94 issue: 1–2 year: 2011 ident: 3515_CR112 publication-title: J Virol Methods doi: 10.1016/j.jviromet.2011.08.020 – ident: 3515_CR12 – volume: 14 start-page: 16 year: 2015 ident: 3515_CR120 publication-title: Curr Opin Virol doi: 10.1016/j.coviro.2015.06.001 – volume: 2 start-page: 275 issue: 3 year: 2014 ident: 3515_CR59 publication-title: Expert Rev Mol Diagn doi: 10.1586/14737159.2.3.275 – volume: 10 start-page: e0118149 issue: 3 year: 2015 ident: 3515_CR121 publication-title: PLoS One doi: 10.1371/journal.pone.0118149 – ident: 3515_CR26 – volume: 29 start-page: 429 issue: 3 year: 2016 ident: 3515_CR97 publication-title: Clin Microbiol Rev doi: 10.1128/CMR.00090-15 – ident: 3515_CR67 – volume: 12 start-page: 1545 issue: 12 year: 1998 ident: 3515_CR43 publication-title: Aids doi: 10.1097/00002030-199812000-00018 – volume: 229 start-page: 35 year: 2016 ident: 3515_CR90 publication-title: J Virol Methods doi: 10.1016/j.jviromet.2015.12.007 – volume: 41 start-page: 1586 issue: 4 year: 2003 ident: 3515_CR33 publication-title: J Clin Microbiol doi: 10.1128/JCM.41.4.1586-1593.2003 – ident: 3515_CR38 – volume: 70 start-page: 153 issue: 2 year: 1998 ident: 3515_CR71 publication-title: J Virol Methods doi: 10.1016/S0166-0934(97)00178-X – volume: 158 start-page: 1158 issue: 6 year: 1988 ident: 3515_CR48 publication-title: J Infect Dis doi: 10.1093/infdis/158.6.1158 – volume: 54 start-page: 220 issue: 1 year: 2016 ident: 3515_CR116 publication-title: J Clin Microbiol doi: 10.1128/JCM.02833-15 – volume: 195 start-page: 951 issue: 7 year: 2007 ident: 3515_CR93 publication-title: J Infect Dis doi: 10.1086/512088 – volume: 13 start-page: 693 issue: 7 year: 2013 ident: 3515_CR41 publication-title: Expert Rev Mol Diagn doi: 10.1586/14737159.2013.829703 – volume: 53 start-page: 1616 issue: 5 year: 2015 ident: 3515_CR101 publication-title: J Clin Microbiol doi: 10.1128/JCM.03325-14 – volume: 7 start-page: e33295 issue: 3 year: 2012 ident: 3515_CR61 publication-title: PLoS One doi: 10.1371/journal.pone.0033295 – volume: 11 start-page: e0152513 issue: 3 year: 2016 ident: 3515_CR135 publication-title: PLoS One doi: 10.1371/journal.pone.0152513 – volume: 53 start-page: 3376 issue: 8 year: 2010 ident: 3515_CR123 publication-title: J Med Chem doi: 10.1021/jm100073m – volume: 96 start-page: 9236 issue: 16 year: 1999 ident: 3515_CR137 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.96.16.9236 – volume: 29 start-page: 331 issue: 3 year: 2015 ident: 3515_CR115 publication-title: Aids doi: 10.1097/QAD.0000000000000556 – volume: 186 start-page: 68 issue: 1–2 year: 2012 ident: 3515_CR151 publication-title: J Virol Methods doi: 10.1016/j.jviromet.2012.08.019 – volume: 9 start-page: 315 issue: 2 year: 2015 ident: 3515_CR70 publication-title: Isbt Science doi: 10.1111/voxs.12106 – volume: 43 start-page: 177 issue: 3 year: 2016 ident: 3515_CR78 publication-title: Transfus Med Hemother doi: 10.1159/000446217 – ident: 3515_CR21 – volume: 12 start-page: 22 issue: 1 year: 2015 ident: 3515_CR157 publication-title: Retrovirology doi: 10.1186/s12977-015-0150-z – volume: 21 start-page: 397 issue: 8 year: 2013 ident: 3515_CR4 publication-title: Trends Microbiol doi: 10.1016/j.tim.2013.06.004 – ident: 3515_CR2 – volume: 70 start-page: 1833 issue: 6 year: 2015 ident: 3515_CR141 publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkv046 – ident: 3515_CR35 – ident: 3515_CR57 doi: 10.16966/2380-5536.135 – volume: 42 start-page: 2711 issue: 6 year: 2004 ident: 3515_CR31 publication-title: J Clin Microbiol doi: 10.1128/JCM.42.6.2711-2717.2004 – ident: 3515_CR30 – volume: 58 start-page: e48 issue: Suppl 1 year: 2013 ident: 3515_CR96 publication-title: J Clin Virol doi: 10.1016/j.jcv.2013.08.005 – volume: 239 start-page: 295 issue: 4837 year: 1988 ident: 3515_CR6 publication-title: Science doi: 10.1126/science.3336784 – volume: 49 start-page: 1382 issue: 4 year: 2011 ident: 3515_CR131 publication-title: J Clin Microbiol doi: 10.1128/JCM.02008-10 – volume: 47 start-page: 889 issue: 4 year: 2009 ident: 3515_CR51 publication-title: J Clin Microbiol doi: 10.1128/JCM.02231-08 – volume: 216 start-page: 1063 issue: 9 year: 2017 ident: 3515_CR122 publication-title: J Infect Dis doi: 10.1093/infdis/jix470 – volume: 54 start-page: 2575 issue: 10 year: 2016 ident: 3515_CR56 publication-title: J Clin Microbiol doi: 10.1128/JCM.01350-16 – volume: 9 start-page: 9 issue: 1 year: 2015 ident: 3515_CR110 publication-title: Open Aids Journal doi: 10.2174/1874613601509010009 – volume: 205 start-page: 521 issue: 4 year: 2012 ident: 3515_CR13 publication-title: J Infect Dis doi: 10.1093/infdis/jir793 – ident: 3515_CR24 – volume: 92 start-page: JVI.01589 issue: 3 year: 2017 ident: 3515_CR147 publication-title: J Virol doi: 10.1128/JVI.01589-17 – volume: 51 start-page: 4137 issue: 12 year: 2013 ident: 3515_CR65 publication-title: J Clin Microbiol doi: 10.1128/JCM.01525-13 – volume: 122 start-page: 185 issue: 2 year: 2004 ident: 3515_CR8 publication-title: J Virol Methods doi: 10.1016/j.jviromet.2004.08.018 – volume: 216 start-page: S824 issue: suppl_9 year: 2017 ident: 3515_CR113 publication-title: J Infect Dis doi: 10.1093/infdis/jix413 – volume: 48 start-page: 1195 issue: 4 year: 2010 ident: 3515_CR16 publication-title: J Clin Microbiol doi: 10.1128/JCM.01832-09 – ident: 3515_CR3 – ident: 3515_CR102 – volume: 14 start-page: 1 issue: S2 year: 2014 ident: 3515_CR109 publication-title: Aids – volume: 7 start-page: 47 issue: 1 year: 2017 ident: 3515_CR125 publication-title: Cell Biosci doi: 10.1186/s13578-017-0174-2 – ident: 3515_CR36 – volume: 38 start-page: 1231 issue: 9 year: 2017 ident: 3515_CR60 publication-title: Zhonghua Liu Xing Bing Xue Za Zhi – volume: 5 start-page: 32 year: 2017 ident: 3515_CR156 publication-title: Front Public Health doi: 10.3389/fpubh.2017.00032 – volume: 743 start-page: 51 issue: 743 year: 2012 ident: 3515_CR87 publication-title: Adv Exp Med Biol doi: 10.1007/978-1-4614-2251-8_4 – volume: 58 start-page: 649 issue: 3 year: 2018 ident: 3515_CR15 publication-title: Transfusion doi: 10.1111/trf.14457 – volume: 71 start-page: 76 year: 2015 ident: 3515_CR55 publication-title: J Clin Virol doi: 10.1016/j.jcv.2015.08.007 – volume: 86 start-page: 10857 issue: 19 year: 2012 ident: 3515_CR142 publication-title: J Virol doi: 10.1128/JVI.01414-12 – volume: 42 start-page: 527 issue: 5 year: 2010 ident: 3515_CR66 publication-title: Transfusion doi: 10.1046/j.1537-2995.2002.00101.x – ident: 3515_CR105 – ident: 3515_CR27 – volume: 12 start-page: e1005545 issue: 4 year: 2016 ident: 3515_CR138 publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1005545 – volume: 28 start-page: 253 issue: 28 year: 1994 ident: 3515_CR49 publication-title: Methods Mol Biol – volume: 14 start-page: 305 issue: 5 year: 2010 ident: 3515_CR62 publication-title: Mol Diagn Ther doi: 10.1007/BF03256386 – volume: 74 start-page: e129 issue: 5 year: 2017 ident: 3515_CR103 publication-title: J Acquir Immune Defic Syndr doi: 10.1097/QAI.0000000000001198 – volume: 96 start-page: 60 year: 2017 ident: 3515_CR80 publication-title: J Clin Virol doi: 10.1016/j.jcv.2017.09.010 – ident: 3515_CR58 doi: 10.1128/JCM.00292-18 – volume: 58 start-page: E24 year: 2013 ident: 3515_CR95 publication-title: J Clin Virol doi: 10.1016/j.jcv.2013.07.016 – volume: 382 start-page: 700 issue: 9893 year: 2013 ident: 3515_CR107 publication-title: Lancet doi: 10.1016/S0140-6736(13)61221-0 – volume: 283 start-page: 1175 issue: 9 year: 2000 ident: 3515_CR83 publication-title: Jama doi: 10.1001/jama.283.9.1175 – volume: 12 start-page: 46 issue: 1 year: 2015 ident: 3515_CR94 publication-title: HIV Med doi: 10.1111/j.1468-1293.2010.00850.x – volume: 188 start-page: 97 issue: 1–2 year: 2013 ident: 3515_CR119 publication-title: J Virol Methods doi: 10.1016/j.jviromet.2012.11.044 – volume: 11 start-page: e0152672 issue: 3 year: 2016 ident: 3515_CR91 publication-title: PLoS One doi: 10.1371/journal.pone.0152672 – volume: 47 start-page: 1783 issue: 10 year: 2007 ident: 3515_CR73 publication-title: Transfusion doi: 10.1111/j.1537-2995.2007.01343.x – volume: 61 start-page: 9 issue: 1 year: 2014 ident: 3515_CR118 publication-title: J Clin Virol doi: 10.1016/j.jcv.2014.06.013 – volume: 15 start-page: 16 issue: 1 year: 2018 ident: 3515_CR149 publication-title: Retrovirology doi: 10.1186/s12977-018-0399-0 – volume: 43 start-page: 462 issue: 6 year: 2015 ident: 3515_CR144 publication-title: Exp Hematol doi: 10.1016/j.exphem.2015.02.006 – ident: 3515_CR22 – volume: 5 start-page: 283 issue: 4 year: 2010 ident: 3515_CR68 publication-title: Curr Opin HIV AIDS doi: 10.1097/COH.0b013e32833a6b11 |
| SSID | ssib020359409 ssib004297703 ssib000223496 ssib001235835 ssib020737988 ssib048395012 ssib021656634 ssib031263309 ssj0007877 |
| Score | 2.362386 |
| SecondaryResourceType | review_article |
| Snippet | Significant advances have been made in the molecular assays used for the detection of human immunodeficiency virus (HIV), which are crucial in preventing HIV... |
| SourceID | proquest pubmed crossref springer nii |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 829 |
| SubjectTerms | Amplification Antiretroviral agents Assaying Biomedical and Life Sciences Biomedicine Chain branching Contamination Deoxyribonucleic acid Diagnosis Disease transmission DNA Drug resistance Genomes Genotype HIV HIV Infections HIV-1 Host-Pathogen Interactions Human immunodeficiency virus Humans Infections Internal Medicine Medical Microbiology Microbial Sensitivity Tests Nucleic Acid Amplification Techniques Nucleic acids Nucleotide sequence Point-of-Care Testing Polymerase chain reaction Polymorphism Reagent Kits, Diagnostic Reproducibility Review Risk reduction RNA, Viral Transcription Viruses |
| SummonAdditionalLinks | – databaseName: SpringerLink Journals (ICM) dbid: U2A link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR3LSsQwMPhA8SK6vlZdieBNC22apslRZJdVWE-u7K3kKQXtilsP_r2TvlR8gJdekg7JzCQzk3khdObixMXGyoBRHQc0VWEghIPjrohkwnFBjX_Qn9yy8ZTezJJZkxS2aKPdW5dkdVN_SnYLfcCsT7qJQQoHYKivJt52By6eksvu_gUWrJKkRUwD31OrSZX5GcYXcbRc5PlPmuY3L2klfEZbaLPRGvFlTeZttGSLHlqr-0i-9dD6pPGQ76DhrS9QnGssdW5w6WtoFA9YFgY_tY1wse6KNNc5mHju8Pj6HreBWcViF01Hw7urcdC0Sgg0TcMyiLTjVKaWOapcoi3sLRWGEaFUahjlkmsLwlwRESYKrGHlGLHOSCZjxyITxntopZgX9gDhyMQARJjItzBy1nJOFbeJFIoTyUXUR1GLsUw3dcR9O4vH7KMCssdyBljOKixnYR-dd_8811U0_pw9AEIAcP-NwKJLQQ-kxPfCA_2JwPhxS6KsOXGLDHbnc3BFyProtBuGs-IdILKw89d6DjCHSADEfk3abjlw1wlQFkUfXbS0_gD--1oP_zf9CG2Qivt8xOQxWilfXu0AtJpSnVRM_A5AMOd0 priority: 102 providerName: Springer Nature |
| Title | Nucleic acid testing and molecular characterization of HIV infections |
| URI | https://cir.nii.ac.jp/crid/1871709542497864320 https://link.springer.com/article/10.1007/s10096-019-03515-0 https://www.ncbi.nlm.nih.gov/pubmed/30798399 https://www.proquest.com/docview/2185197906 https://www.proquest.com/docview/2185877950 |
| Volume | 38 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELfYJhAvCAaMwjYZiTewSBzHsZ9Qi1oKaBVCFJWnyJ-oEqSDdg_899wlTioE7CV5sHNy7s6-s313P0KexaKMhQ-GSeEKJiqbMa0jTHfLjdRRaeHxQP9iIedL8W5VrtKB2zaFVfZrYrtQ-43DM_KXYIowx1Jn8tXlD4aoUXi7miA0DsgRli7DkK5qNWy4wPq1yIuwaRcM0bVS0kxKncsw_BZTeAqw6Sz7wzAdNOv1v3zOv-5LWzM0u0vuJP-RjjuB3yM3QnNMbnaIkr-Oya2LdFd-n0wXWKp47ahxa093WE2j-UpN4-n3HhKXuqFcc5eNSTeRzt9-pn2IVrN9QJaz6afXc5ZAE5gTVbZjuYtKmCrIKGwsXYB_q7SXXFtbeSmUUS4ALy3XWWlhX2yj5CF6I00RZe6z4iE5bDZNeERo7gsgon2OYEYxBKWEVaE02ipulM5HJO85VrtUURyBLb7V-1rIyOUauFy3XK6zEXk-fHPZ1dO4tvcZCAKI4zOHvV0FHqHgiIoHnhSH9tNeRHWae9t6rykj8nRohlmDVyGmCZurrg8ohy6BxEkn2mE4sOppcBv1iLzoZb0n_v-xPr5-LE_Ibd5qG8ZKnpLD3c-rcAb-zM6et0p7To7Gs8lkge83X95P4T2ZLj58hNYlH_8GVjbwNg |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxEB61qXhcEJRXoAUjwQksdr1er31AiEeqhDYRQi3qbesnigSbQlKh_il-I-N9RQjorZe92Du2ZsaeGdszH8DTkOUhc15TwW1GeWESqlTA5W6YFipIxV080J_OxPiIfzjOjzfgV5cLE59VdntivVG7hY1n5C_RFMUcS5WI16ffaUSNirerHYRGoxb7_vwnhmzLV5P3KN9njO2NDt-NaYsqQC0vkhVNbZBcF14EbkJuPRr0QjnBlDGFE1xqaT0OZphKcoOBowmC-eC00FkQqUsypLsJWzzDUGYAW29Hs4-f-r0f1b9O0FYZpxHPq03TaZP1kvjgNyYNZTgoTf4whZvVfP4vL_evG9ra8O3dhButx0reNCp2CzZ8tQ1XGgzL8224Om1v52_DaBaLI88t0XbuyCrW76i-EF058q0D4SW2LxDd5H-SRSDjyWfSPQqrlnfg6FIYehcG1aLy94GkLkMiyqURPil4LyU30udaGcm0VOkQ0o5jpW1rmEcoja_luvpy5HKJXC5rLpfJEJ73_5w2FTwu7L2LgkDi8ZtiNFmgD8pZxOFD341h-04norJd7ctyrZtDeNI34zqNly-68ouzpg8qh8qRxL1GtP10cJ9V6KiqIbzoZL0m_v-5Prh4Lo_h2vhwelAeTGb7D-E6qzUvvtTcgcHqx5nfRW9qZR61Kkzg5LJXzW-ZAint |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB61RVS9ICiPLm3BSHCCqInjOPEBIUS72qV0xYGivQU_0UpttrBbVf1r_Dpm8lohoLdecrEzsebhGccz8wG8DGkWUud1JIVNI5GbOFIqoLkbrqUKhRKOfuifTOToVHycZtM1-NXVwlBaZbcn1hu1m1v6R36ArohqLFUsD0KbFvH5cPju4kdECFJ009rBaTQqcuyvr_D4tng7PkRZv-J8ePTlwyhqEQYiK_J4GSU2FELnXgZhQmY9OvdcOcmVMbmTotCF9fhhw1WcGTxEmiC5D05LnQaZuDhFuutwJ0-zhGwsn_aHPfS8NepjrFIREbJXW7DTlu3FlPpL5UP4ZhbFfzjF9Wo2-1e8-9ddbe0Ch_fhXhu7sveNsj2ANV9tw90GzfJ6GzZP2nv6h3A0oTbJM8u0nTm2pE4e1XemK8fOOzheZvtW0U0lKJsHNhp_ZV16WLV4BKe3ws7HsFHNK78DLHEpElEuISCl4H1RCFP4TCtTcF2oZABJx7HStt3MCVTjrFz1YSYul8jlsuZyGQ_gdf_ORdPL48bZ-ygIJE7PBM-VOUajghMiH0ZxHMf3OhGVrd0vypWWDuBFP4wWS9cwuvLzy2YOKofKkMSTRrT9cnDHVRiyqgG86WS9Iv7_tT69eS3PYRNtpfw0nhzvwhavFY9SNvdgY_nz0u9jWLU0z2r9ZfDttg3mN5ltLL0 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nucleic+acid+testing+and+molecular+characterization+of+HIV+infections&rft.jtitle=European+journal+of+clinical+microbiology+%26+infectious+diseases&rft.au=Zhao%2C+Junpeng&rft.au=Chang%2C+Le&rft.au=Wang%2C+Lunan&rft.date=2019-05-01&rft.issn=0934-9723&rft.eissn=1435-4373&rft.volume=38&rft.issue=5&rft.spage=829&rft.epage=842&rft_id=info:doi/10.1007%2Fs10096-019-03515-0&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s10096_019_03515_0 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0934-9723&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0934-9723&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0934-9723&client=summon |